CleftGeneDB-Search

Gene: GSTP1

Basic information

Tag	Content
Uniprot ID	P09211; O00460; Q15690; Q5TZY3;
Entrez ID	2950
Genbank protein ID	AAC51237.1; AAV38753.1; AAA56823.1; AAV38752.1; CAA33508.1; CAG29357.1; AAP72967.1; CAA30894.1; CAA29794.1; CAA30847.1; AAA64919.1; AAC51280.1; AAC13869.1; AAH10915.1;
Genbank nucleotide ID	NM_000852.3
Ensembl protein ID	ENSP00000381607
Ensembl nucleotide ID	ENSG00000084207
Gene name	Glutathione S-transferase P
Gene symbol	GSTP1
Organism	Homo sapiens
NCBI taxa ID	9606
Cleft type	CPO,CL/P
Developmental stage
Data sources	Manually collected
Reference	18159215
Functional description	Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2) (PubMed:9084911). Participates in the formation of novel hepoxilin regioisomers (PubMed:21046276). Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration.
Sequence	MPPYTVVYFP VRGRCAALRM LLADQGQSWK EEVVTVETWQ EGSLKASCLY GQLPKFQDGD 60 LTLYQSNTIL RHLGRTLGLY GKDQQEAALV DMVNDGVEDL RCKYISLIYT NYEAGKDDYV 120 KALPGQLKPF ETLLSQNQGG KTFIVGDQIS FADYNLLDLL LIHEVLAPGC LDAFPLLSAY 180 VGRLSARPKL KAFLASPEYV NLPINGNGKQ

Abbreviation :
CLO : cleft lip only. CPO : cleft palate only. CLP : cleft lip and palate. CL/P : cleft lip with/without cleft palate.
For humans: CL/P, CLO, CPO, and CLP. For mice: CLO, CLP, and CPO.

Gene expression information

Gene expression in different tissues (GTEx V7)

Gene expression in different tissues (ENCODE)

Protein structural annotations

3D structure in PDB database

PDB ID
10GS
11GS
12GS
13GS
14GS
16GS
17GS
18GS
19GS
1AQV
1AQW
1AQX
1EOG
1EOH
1GSS
1KBN
1LBK
1MD3
1MD4
1PGT
1PX6
1PX7
1ZGN
20GS
22GS
2A2R
2A2S
2GSS
2J9H
2PGT
3CSH
3CSI
3CSJ
3DD3
3DGQ
3GSS
3GUS
3HJM
3HJO
3HKR
3IE3
3KM6
3KMN
3KMO
3N9J
3PGT
4GSS
4PGT
5DAK
5DAL
5DCG
5DDL
5DJL
5DJM
5GSS
5J41
5JCW
5L6X
5X79
6AP9
6GSS
6Y1E
7GSS
8GSS
9GSS
3KMN
5J41

Protein disorder information

Orthologous information

There is no orthologous record for this gene !

Identified variants/mutations related to cleft phenotype

Gene symbol	Significant Variants/SNPS	Methods	PubMed ID
GSTP1	I105V	TDT	18159215

Other genetic variants/mutations

ID	Variant	Type	Disease	Chromosome\Coordinate	Evidence
rs748870439	p.Pro2Leu	missense variant	-	NC_000011.10:g.67584137C>T	ExAC,gnomAD
rs747863009	p.Pro3Arg	missense variant	-	NC_000011.10:g.67584140C>G	ExAC,gnomAD
rs778676080	p.Pro3Thr	missense variant	-	NC_000011.10:g.67584139C>A	ExAC,gnomAD
rs1259510547	p.Tyr4Cys	missense variant	-	NC_000011.10:g.67584143A>G	gnomAD
rs1197989614	p.Val7Phe	missense variant	-	NC_000011.10:g.67584151G>T	gnomAD
rs772897689	p.Tyr8Cys	missense variant	-	NC_000011.10:g.67584155A>G	ExAC,gnomAD
rs770921838	p.Val11Ala	missense variant	-	NC_000011.10:g.67584164T>C	ExAC,gnomAD
rs372703452	p.Arg12Gly	missense variant	-	NC_000011.10:g.67584166C>G	ESP,ExAC,TOPMed,gnomAD
rs372703452	p.Arg12Ter	stop gained	-	NC_000011.10:g.67584166C>T	ESP,ExAC,TOPMed,gnomAD
rs764194048	p.Arg12Pro	missense variant	-	NC_000011.10:g.67584167G>C	ExAC,gnomAD
rs560001291	p.Arg14Cys	missense variant	-	NC_000011.10:g.67584466C>T	1000Genomes,ExAC
rs1469428072	p.Arg14Leu	missense variant	-	NC_000011.10:g.67584467G>T	TOPMed
rs1398861223	p.Cys15Tyr	missense variant	-	NC_000011.10:g.67584470G>A	gnomAD
rs768734901	p.Cys15Trp	missense variant	-	NC_000011.10:g.67584471C>G	ExAC,TOPMed,gnomAD
rs1242562303	p.Ala16Gly	missense variant	-	NC_000011.10:g.67584473C>G	TOPMed,gnomAD
rs1242562303	p.Ala16Glu	missense variant	-	NC_000011.10:g.67584473C>A	TOPMed,gnomAD
rs774305853	p.Ala16Thr	missense variant	-	NC_000011.10:g.67584472G>A	ExAC,gnomAD
rs1425920131	p.Ala17Thr	missense variant	-	NC_000011.10:g.67584475G>A	gnomAD
rs12796085	p.Leu18Val	missense variant	-	NC_000011.10:g.67584478C>G	ExAC,TOPMed,gnomAD
rs1354173738	p.Arg19Cys	missense variant	-	NC_000011.10:g.67584481C>T	TOPMed,gnomAD
rs781578393	p.Arg19His	missense variant	-	NC_000011.10:g.67584482G>A	TOPMed,gnomAD
rs781578393	p.Arg19Leu	missense variant	-	NC_000011.10:g.67584482G>T	TOPMed,gnomAD
rs767694369	p.Met20Leu	missense variant	-	NC_000011.10:g.67584484A>T	ExAC,TOPMed,gnomAD
rs767694369	p.Met20Val	missense variant	-	NC_000011.10:g.67584484A>G	ExAC,TOPMed,gnomAD
rs773694545	p.Met20Ile	missense variant	-	NC_000011.10:g.67584486G>C	ExAC,gnomAD
rs761170136	p.Leu21Gln	missense variant	-	NC_000011.10:g.67584488T>A	ExAC,gnomAD
rs192307201	p.Ala23Ser	missense variant	-	NC_000011.10:g.67584493G>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs754355118	p.Ala23Val	missense variant	-	NC_000011.10:g.67584494C>T	ExAC,TOPMed,gnomAD
rs755557033	p.Gln25Glu	missense variant	-	NC_000011.10:g.67584499C>G	ExAC,TOPMed,gnomAD
rs752215721	p.Ser28Arg	missense variant	-	NC_000011.10:g.67584510C>A	ExAC,TOPMed,gnomAD
rs764740104	p.Ser28Thr	missense variant	-	NC_000011.10:g.67584509G>C	ExAC,gnomAD
rs551651791	p.Trp29Ter	stop gained	-	NC_000011.10:g.67584513G>A	1000Genomes
NCI-TCGA novel	p.Glu31Lys	missense variant	-	NC_000011.10:g.67584517G>A	NCI-TCGA
rs1304384783	p.Glu31Asp	missense variant	-	NC_000011.10:g.67584519G>T	TOPMed,gnomAD
rs45506591	p.Glu32Val	missense variant	-	NC_000011.10:g.67584521A>T	ESP,ExAC,TOPMed,gnomAD
rs758057623	p.Glu32Lys	missense variant	-	NC_000011.10:g.67584520G>A	ExAC,gnomAD
rs1380769044	p.Val33Met	missense variant	-	NC_000011.10:g.67584523G>A	gnomAD
rs746780344	p.Val34Leu	missense variant	-	NC_000011.10:g.67584526G>T	ExAC,TOPMed,gnomAD
rs1377458828	p.Val36Met	missense variant	-	NC_000011.10:g.67584532G>A	gnomAD
rs757009510	p.Val36Ala	missense variant	-	NC_000011.10:g.67584533T>C	ExAC,gnomAD
rs1283707278	p.Glu37Ter	stop gained	-	NC_000011.10:g.67584535G>T	TOPMed,gnomAD
rs1215402584	p.Thr38Met	missense variant	-	NC_000011.10:g.67584539C>T	gnomAD
rs745744788	p.Trp39Arg	missense variant	-	NC_000011.10:g.67584541T>C	ExAC,gnomAD
rs769620801	p.Glu41Gly	missense variant	-	NC_000011.10:g.67584548A>G	ExAC,gnomAD
rs774481007	p.Ser43Leu	missense variant	-	NC_000011.10:g.67584554C>T	ExAC,gnomAD
rs1164730655	p.Ala46Val	missense variant	-	NC_000011.10:g.67584563C>T	TOPMed
rs765505289	p.Ser47Thr	missense variant	-	NC_000011.10:g.67584565T>A	TOPMed,gnomAD
rs369083008	p.Cys48Phe	missense variant	-	NC_000011.10:g.67584569G>T	ESP,ExAC,TOPMed,gnomAD
rs8191448	p.Tyr50Ter	stop gained	-	NC_000011.10:g.67584690C>G	1000Genomes,ESP,ExAC,TOPMed,gnomAD
COSM4927905	p.Tyr50His	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000011.10:g.67584688T>C	NCI-TCGA Cosmic
rs1365217261	p.Gly51Arg	missense variant	-	NC_000011.10:g.67584691G>A	gnomAD
rs771348326	p.Gln52Ter	stop gained	-	NC_000011.10:g.67584694C>T	ExAC
rs1217728595	p.Pro54Arg	missense variant	-	NC_000011.10:g.67584701C>G	TOPMed,gnomAD
rs759868205	p.Phe56Ile	missense variant	-	NC_000011.10:g.67584706T>A	ExAC
rs45543438	p.Asp58Asn	missense variant	-	NC_000011.10:g.67584712G>A	ESP,ExAC,TOPMed,gnomAD
rs1420873262	p.Leu61His	missense variant	-	NC_000011.10:g.67584722T>A	TOPMed
rs200701643	p.Leu61Phe	missense variant	-	NC_000011.10:g.67584721C>T	ESP,ExAC,TOPMed,gnomAD
rs763540257	p.Thr62Ile	missense variant	-	NC_000011.10:g.67584725C>T	ExAC,TOPMed,gnomAD
rs373014884	p.Ser66Tyr	missense variant	-	NC_000011.10:g.67584737C>A	ESP,ExAC,TOPMed,gnomAD
rs371145062	p.Ser66Ala	missense variant	-	NC_000011.10:g.67584736T>G	ESP,TOPMed
rs373014884	p.Ser66Phe	missense variant	-	NC_000011.10:g.67584737C>T	ESP,ExAC,TOPMed,gnomAD
rs377655015	p.Asn67Asp	missense variant	-	NC_000011.10:g.67584739A>G	ESP,ExAC,TOPMed,gnomAD
rs1200793614	p.Asn67Ser	missense variant	-	NC_000011.10:g.67584740A>G	TOPMed
COSM4402110	p.Asn67Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000011.10:g.67584740A>C	NCI-TCGA Cosmic
COSM1475823	p.Thr68Ser	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000011.10:g.67584743C>G	NCI-TCGA Cosmic
rs779929728	p.Leu70Arg	missense variant	-	NC_000011.10:g.67584749T>G	ExAC,gnomAD
NCI-TCGA novel	p.Arg71Gly	missense variant	-	NC_000011.10:g.67584751C>G	NCI-TCGA
rs752731774	p.Arg71His	missense variant	-	NC_000011.10:g.67584752G>A	ExAC,gnomAD
rs1167850587	p.Arg71Cys	missense variant	-	NC_000011.10:g.67584751C>T	gnomAD
rs754955382	p.His72Asn	missense variant	-	NC_000011.10:g.67584754C>A	ExAC,TOPMed,gnomAD
rs777997068	p.His72Arg	missense variant	-	NC_000011.10:g.67584755A>G	ExAC,gnomAD
NCI-TCGA novel	p.Gly74AlaPheSerTerUnkUnk	frameshift	-	NC_000011.10:g.67584759G>-	NCI-TCGA
rs1404050687	p.Arg75Cys	missense variant	-	NC_000011.10:g.67584763C>T	gnomAD
rs771256487	p.Arg75His	missense variant	-	NC_000011.10:g.67584764G>A	ExAC,gnomAD
rs771256487	p.Arg75Leu	missense variant	-	NC_000011.10:g.67584764G>T	ExAC,gnomAD
rs781605862	p.Thr76Ser	missense variant	-	NC_000011.10:g.67584767C>G	ExAC,gnomAD
rs1401936187	p.Gly78Arg	missense variant	-	NC_000011.10:g.67584772G>C	gnomAD
rs1281464190	p.Leu79Phe	missense variant	-	NC_000011.10:g.67585140C>T	TOPMed,gnomAD
rs1384444513	p.Tyr80His	missense variant	-	NC_000011.10:g.67585143T>C	gnomAD
rs372794640	p.Gln84His	missense variant	-	NC_000011.10:g.67585157G>T	ESP
rs1415126258	p.Gln84Lys	missense variant	-	NC_000011.10:g.67585155C>A	gnomAD
rs1466304905	p.Gln85Arg	missense variant	-	NC_000011.10:g.67585159A>G	TOPMed
rs1336312256	p.Ala88Ser	missense variant	-	NC_000011.10:g.67585167G>T	gnomAD
rs1404000028	p.Ala88Asp	missense variant	-	NC_000011.10:g.67585168C>A	gnomAD
rs776268350	p.Val90Gly	missense variant	-	NC_000011.10:g.67585174T>G	ExAC,TOPMed,gnomAD
rs776268350	p.Val90Ala	missense variant	-	NC_000011.10:g.67585174T>C	ExAC,TOPMed,gnomAD
rs1310598334	p.Val90Met	missense variant	-	NC_000011.10:g.67585173G>A	gnomAD
rs1237280319	p.Asp91Glu	missense variant	-	NC_000011.10:g.67585178C>G	gnomAD
rs202114011	p.Met92Thr	missense variant	-	NC_000011.10:g.67585180T>C	1000Genomes,ExAC,gnomAD
rs1209215477	p.Met92Val	missense variant	-	NC_000011.10:g.67585179A>G	gnomAD
rs990829761	p.Asp95Tyr	missense variant	-	NC_000011.10:g.67585188G>T	gnomAD
rs758425456	p.Gly96Ser	missense variant	-	NC_000011.10:g.67585191G>A	ExAC,TOPMed,gnomAD
rs374158536	p.Val97Met	missense variant	-	NC_000011.10:g.67585194G>A	ESP,TOPMed,gnomAD
rs1180757968	p.Asp99Tyr	missense variant	-	NC_000011.10:g.67585200G>T	gnomAD
rs1478519359	p.Asp99Glu	missense variant	-	NC_000011.10:g.67585202C>A	gnomAD
rs767434442	p.Arg101Cys	missense variant	-	NC_000011.10:g.67585206C>T	ExAC,TOPMed,gnomAD
rs1191943674	p.Arg101His	missense variant	-	NC_000011.10:g.67585207G>A	TOPMed,gnomAD
rs750586939	p.Cys102Ser	missense variant	-	NC_000011.10:g.67585210G>C	ExAC,TOPMed,gnomAD
rs1451964684	p.Lys103Asn	missense variant	-	NC_000011.10:g.67585214A>C	TOPMed
rs1402998982	p.Lys103Glu	missense variant	-	NC_000011.10:g.67585212A>G	gnomAD
rs1259485839	p.Tyr104Cys	missense variant	-	NC_000011.10:g.67585216A>G	TOPMed
rs765946068	p.Tyr104Ter	stop gained	-	NC_000011.10:g.67585216dup	ExAC,gnomAD
RCV000437330	p.Ile105Val	missense variant	Neoplasm of the large intestine	NC_000011.10:g.67585218A>G	ClinVar
rs1695	p.Ile105Val	missense variant	-	NC_000011.10:g.67585218A>G	UniProt,dbSNP
VAR_014499	p.Ile105Val	missense variant	-	NC_000011.10:g.67585218A>G	UniProt
rs1695	p.Ile105Val	missense variant	-	NC_000011.10:g.67585218A>G	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs533546581	p.Ser106Phe	missense variant	-	NC_000011.10:g.67585222C>T	1000Genomes,ExAC,TOPMed,gnomAD
rs1218642610	p.Leu107His	missense variant	-	NC_000011.10:g.67585225T>A	TOPMed,gnomAD
rs749618287	p.Leu107Phe	missense variant	-	NC_000011.10:g.67585224C>T	ExAC,gnomAD
rs199833944	p.Ile108Phe	missense variant	-	NC_000011.10:g.67585227A>T	ExAC,TOPMed,gnomAD
rs4986948	p.Thr110Ser	missense variant	-	NC_000011.10:g.67585234C>G	ESP,ExAC,TOPMed,gnomAD
rs746579636	p.Asn111Asp	missense variant	-	NC_000011.10:g.67585236A>G	ExAC,TOPMed,gnomAD
rs770460061	p.Tyr112His	missense variant	-	NC_000011.10:g.67585239T>C	ExAC,gnomAD
rs563603340	p.Tyr112Cys	missense variant	-	NC_000011.10:g.67585240A>G	1000Genomes,ExAC,TOPMed,gnomAD
rs770460061	p.Tyr112Asp	missense variant	-	NC_000011.10:g.67585239T>G	ExAC,gnomAD
rs770427889	p.Glu113Lys	missense variant	-	NC_000011.10:g.67586104G>A	ExAC
rs770427889	p.Glu113Gln	missense variant	-	NC_000011.10:g.67586104G>C	ExAC
rs1138272	p.Ala114Val	missense variant	-	NC_000011.10:g.67586108C>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs377625632	p.Gly115Asp	missense variant	-	NC_000011.10:g.67586111G>A	ESP,ExAC,gnomAD
rs1382173535	p.Gly115Ser	missense variant	-	NC_000011.10:g.67586110G>A	gnomAD
rs369682039	p.Lys116Glu	missense variant	-	NC_000011.10:g.67586113A>G	ESP,ExAC,TOPMed,gnomAD
rs768442916	p.Asp117Asn	missense variant	-	NC_000011.10:g.67586116G>A	ExAC,gnomAD
rs768442916	p.Asp117Tyr	missense variant	-	NC_000011.10:g.67586116G>T	ExAC,gnomAD
NCI-TCGA novel	p.Asp118Tyr	missense variant	-	NC_000011.10:g.67586119G>T	NCI-TCGA
rs774302901	p.Val120Met	missense variant	-	NC_000011.10:g.67586125G>A	ExAC,gnomAD
rs78507509	p.Pro124Ala	missense variant	-	NC_000011.10:g.67586137C>G	1000Genomes,ExAC,TOPMed,gnomAD
rs78507509	p.Pro124Ser	missense variant	-	NC_000011.10:g.67586137C>T	1000Genomes,ExAC,TOPMed,gnomAD
rs377602132	p.Gly125Arg	missense variant	-	NC_000011.10:g.67586140G>A	ESP,ExAC,TOPMed,gnomAD
rs759750120	p.Gly125Glu	missense variant	-	NC_000011.10:g.67586141G>A	ExAC,TOPMed,gnomAD
rs765500099	p.Leu127Val	missense variant	-	NC_000011.10:g.67586146C>G	ExAC,TOPMed,gnomAD
rs758749778	p.Pro129Ser	missense variant	-	NC_000011.10:g.67586152C>T	ExAC,gnomAD
rs370396702	p.Phe130Val	missense variant	-	NC_000011.10:g.67586155T>G	ESP,TOPMed
rs1392957952	p.Phe130Leu	missense variant	-	NC_000011.10:g.67586157T>A	TOPMed
rs778023522	p.Thr132Ile	missense variant	-	NC_000011.10:g.67586162C>T	ExAC,TOPMed,gnomAD
rs1406534057	p.Ser135Phe	missense variant	-	NC_000011.10:g.67586171C>T	gnomAD
NCI-TCGA novel	p.Gln138His	missense variant	-	NC_000011.10:g.67586181G>C	NCI-TCGA
rs780849388	p.Gln138Ter	stop gained	-	NC_000011.10:g.67586179C>T	ExAC,gnomAD
rs71534227	p.Gly139Glu	missense variant	-	NC_000011.10:g.67586183G>A	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs769545271	p.Gly140Val	missense variant	-	NC_000011.10:g.67586186G>T	ExAC,gnomAD
rs553211668	p.Lys141Arg	missense variant	-	NC_000011.10:g.67586189A>G	1000Genomes,ExAC,gnomAD
rs748921331	p.Ile144Leu	missense variant	-	NC_000011.10:g.67586197A>C	ExAC
rs199949339	p.Ile144Thr	missense variant	-	NC_000011.10:g.67586198T>C	1000Genomes,ESP,ExAC,TOPMed,gnomAD
COSM1298508	p.Gly146Val	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000011.10:g.67586204G>T	NCI-TCGA Cosmic
rs4986949	p.Asp147Tyr	missense variant	-	NC_000011.10:g.67586206G>T	1000Genomes,ExAC,TOPMed,gnomAD
rs772064183	p.Asp147Glu	missense variant	-	NC_000011.10:g.67586208C>A	ExAC,gnomAD
rs777261816	p.Phe151Leu	missense variant	-	NC_000011.10:g.67586397C>G	ExAC,TOPMed,gnomAD
rs762120399	p.Ala152Thr	missense variant	-	NC_000011.10:g.67586398G>A	ExAC,TOPMed,gnomAD
rs750205427	p.Asp153Glu	missense variant	-	NC_000011.10:g.67586403C>A	ExAC,gnomAD
rs750908433	p.Tyr154His	missense variant	-	NC_000011.10:g.67586404T>C	ExAC,gnomAD
rs746337625	p.Asn155His	missense variant	-	NC_000011.10:g.67586407A>C	ExAC,gnomAD
rs746337625	p.Asn155Asp	missense variant	-	NC_000011.10:g.67586407A>G	ExAC,gnomAD
rs1423718825	p.Leu157Pro	missense variant	-	NC_000011.10:g.67586414T>C	gnomAD
rs71534294	p.Asp158His	missense variant	-	NC_000011.10:g.67586416G>C	ESP,ExAC,TOPMed,gnomAD
rs199567349	p.Leu160Met	missense variant	-	NC_000011.10:g.67586422C>A	1000Genomes,ExAC,gnomAD
rs201449696	p.Ile162Leu	missense variant	-	NC_000011.10:g.67586428A>C	1000Genomes,ExAC,TOPMed,gnomAD
COSM690340	p.His163Tyr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000011.10:g.67586431C>T	NCI-TCGA Cosmic
rs377297283	p.Leu166Val	missense variant	-	NC_000011.10:g.67586440C>G	ESP,ExAC,TOPMed,gnomAD
rs369555354	p.Ala167Val	missense variant	-	NC_000011.10:g.67586444C>T	ESP,ExAC,TOPMed,gnomAD
COSM1356454	p.Ala167Asp	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000011.10:g.67586444C>A	NCI-TCGA Cosmic
rs41462048	p.Gly169Asp	missense variant	-	NC_000011.10:g.67586450G>A	-
rs41462048	p.Gly169Asp	missense variant	-	NC_000011.10:g.67586450G>A	UniProt,dbSNP
VAR_049493	p.Gly169Asp	missense variant	-	NC_000011.10:g.67586450G>A	UniProt
rs746884675	p.Gly169Ser	missense variant	-	NC_000011.10:g.67586449G>A	ExAC,gnomAD
rs770923997	p.Asp172Glu	missense variant	-	NC_000011.10:g.67586460T>G	ExAC,gnomAD
rs1025117296	p.Ala173Val	missense variant	-	NC_000011.10:g.67586462C>T	gnomAD
rs374283345	p.Phe174Ser	missense variant	-	NC_000011.10:g.67586465T>C	ESP,ExAC,TOPMed,gnomAD
rs768896121	p.Phe174Ile	missense variant	-	NC_000011.10:g.67586464T>A	ExAC,TOPMed,gnomAD
rs768896121	p.Phe174Leu	missense variant	-	NC_000011.10:g.67586464T>C	ExAC,TOPMed,gnomAD
rs1459434861	p.Pro175Ala	missense variant	-	NC_000011.10:g.67586467C>G	TOPMed,gnomAD
rs772503886	p.Pro175Leu	missense variant	-	NC_000011.10:g.67586468C>T	ExAC,gnomAD
rs1459434861	p.Pro175Ser	missense variant	-	NC_000011.10:g.67586467C>T	TOPMed,gnomAD
rs766852045	p.Leu176Pro	missense variant	-	NC_000011.10:g.67586471T>C	ExAC,gnomAD
rs11553892	p.Leu176Met	missense variant	-	NC_000011.10:g.67586470C>A	ExAC,gnomAD
rs11553892	p.Leu176Val	missense variant	-	NC_000011.10:g.67586470C>G	ExAC,gnomAD
COSM931131	p.Ser178Leu	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000011.10:g.67586477C>T	NCI-TCGA Cosmic
rs753365034	p.Ala179Pro	missense variant	-	NC_000011.10:g.67586479G>C	ExAC,TOPMed,gnomAD
rs764825565	p.Gly182Arg	missense variant	-	NC_000011.10:g.67586488G>C	ExAC,gnomAD
rs188653023	p.Arg183His	missense variant	-	NC_000011.10:g.67586492G>A	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs752233998	p.Arg183Gly	missense variant	-	NC_000011.10:g.67586491C>G	ExAC,TOPMed,gnomAD
rs752233998	p.Arg183Cys	missense variant	-	NC_000011.10:g.67586491C>T	ExAC,TOPMed,gnomAD
COSM3791866	p.Arg183Pro	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000011.10:g.67586492G>C	NCI-TCGA Cosmic
rs777541810	p.Leu184Phe	missense variant	-	NC_000011.10:g.67586494C>T	ExAC,TOPMed,gnomAD
rs757168956	p.Ala186Ser	missense variant	-	NC_000011.10:g.67586500G>T	ExAC,TOPMed,gnomAD
rs757168956	p.Ala186Thr	missense variant	-	NC_000011.10:g.67586500G>A	ExAC,TOPMed,gnomAD
rs768565704	p.Arg187Gln	missense variant	-	NC_000011.10:g.67586504G>A	ExAC,TOPMed,gnomAD
rs45549733	p.Arg187Trp	missense variant	-	NC_000011.10:g.67586503C>T	ExAC,TOPMed,gnomAD
rs45549733	p.Arg187Gly	missense variant	-	NC_000011.10:g.67586503C>G	ExAC,TOPMed,gnomAD
rs541789217	p.Pro188Leu	missense variant	-	NC_000011.10:g.67586507C>T	ExAC,gnomAD
NCI-TCGA novel	p.Lys189ProPheSerTerUnkUnk	frameshift	-	NC_000011.10:g.67586505_67586506insCC	NCI-TCGA
rs1039689616	p.Lys191Arg	missense variant	-	NC_000011.10:g.67586516A>G	TOPMed,gnomAD
rs773696694	p.Ala192Val	missense variant	-	NC_000011.10:g.67586519C>T	ExAC,TOPMed,gnomAD
rs772487496	p.Ala192Pro	missense variant	-	NC_000011.10:g.67586518G>C	ExAC,gnomAD
rs773696694	p.Ala192Asp	missense variant	-	NC_000011.10:g.67586519C>A	ExAC,TOPMed,gnomAD
COSM3452346	p.Phe193Ser	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000011.10:g.67586522T>C	NCI-TCGA Cosmic
rs1332700236	p.Leu194Val	missense variant	-	NC_000011.10:g.67586524C>G	gnomAD
rs1212970570	p.Ala195Val	missense variant	-	NC_000011.10:g.67586528C>T	gnomAD
rs1448232755	p.Ala195Thr	missense variant	-	NC_000011.10:g.67586527G>A	gnomAD
rs191595383	p.Pro197Ala	missense variant	-	NC_000011.10:g.67586533C>G	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs776954260	p.Glu198Ala	missense variant	-	NC_000011.10:g.67586537A>C	ExAC,TOPMed,gnomAD
rs538776740	p.Tyr199Ter	stop gained	-	NC_000011.10:g.67586541C>A	1000Genomes,ExAC,TOPMed,gnomAD
rs779834912	p.Val200Leu	missense variant	-	NC_000011.10:g.67586542G>C	ExAC,TOPMed,gnomAD
rs779834912	p.Val200Met	missense variant	-	NC_000011.10:g.67586542G>A	ExAC,TOPMed,gnomAD
rs376074280	p.Asn201Thr	missense variant	-	NC_000011.10:g.67586546A>C	1000Genomes,ESP,ExAC,TOPMed,gnomAD
COSM931134	p.Asn201Asp	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000011.10:g.67586545A>G	NCI-TCGA Cosmic
NCI-TCGA novel	p.Pro203Leu	missense variant	-	NC_000011.10:g.67586552C>T	NCI-TCGA
rs762582956	p.Ile204Val	missense variant	-	NC_000011.10:g.67586554A>G	ExAC,gnomAD
rs1014148882	p.Asn205Lys	missense variant	-	NC_000011.10:g.67586559T>G	TOPMed
rs1316398882	p.Asn207His	missense variant	-	NC_000011.10:g.67586563A>C	gnomAD
rs751328497	p.Gly208Arg	missense variant	-	NC_000011.10:g.67586566G>A	ExAC,TOPMed,gnomAD
rs1248232455	p.Lys209Ter	stop gained	-	NC_000011.10:g.67586569A>T	gnomAD

Disease or phenotype associated information

Disease ID	Disease Name	Disease Type	Source
C0000768	Congenital Abnormality	group	BEFREE
C0001418	Adenocarcinoma	group	BEFREE;LHGDN
C0001430	Adenoma	group	BEFREE;LHGDN
C0002395	Alzheimer's Disease	disease	BEFREE;LHGDN
C0002726	Amyloidosis	disease	BEFREE
C0002736	Amyotrophic Lateral Sclerosis	disease	CTD_human;LHGDN
C0002871	Anemia	disease	BEFREE
C0002874	Aplastic Anemia	disease	BEFREE
C0003873	Rheumatoid Arthritis	disease	BEFREE
C0003949	Asbestosis	disease	LHGDN
C0004096	Asthma	disease	BEFREE;CTD_human;LHGDN
C0004114	Astrocytoma	disease	BEFREE;LHGDN
C0004352	Autistic Disorder	group	BEFREE;CTD_human
C0004403	Autosome Abnormalities	group	CTD_human
C0004509	Azoospermia	disease	BEFREE
C0004698	Balkan Nephropathy	disease	BEFREE
C0004763	Barrett Esophagus	disease	BEFREE;LHGDN
C0004779	Basal Cell Nevus Syndrome	disease	BEFREE
C0005684	Malignant neoplasm of urinary bladder	disease	BEFREE;CTD_human;RGD
C0005686	Urinary Bladder Diseases	group	LHGDN
C0005695	Bladder Neoplasm	group	BEFREE;CTD_human;LHGDN;RGD
C0006118	Brain Neoplasms	group	BEFREE;LHGDN
C0006142	Malignant neoplasm of breast	disease	BEFREE;CTD_human
C0006287	Bronchopulmonary Dysplasia	disease	BEFREE
C0007097	Carcinoma	group	CTD_human
C0007102	Malignant tumor of colon	disease	BEFREE
C0007103	Malignant neoplasm of endometrium	disease	BEFREE
C0007107	Malignant neoplasm of larynx	disease	BEFREE
C0007112	Adenocarcinoma of prostate	disease	BEFREE
C0007113	Rectal Carcinoma	disease	BEFREE
C0007114	Malignant neoplasm of skin	disease	BEFREE
C0007115	Malignant neoplasm of thyroid	disease	BEFREE
C0007121	Bronchogenic Carcinoma	disease	BEFREE
C0007124	Noninfiltrating Intraductal Carcinoma	disease	BEFREE
C0007131	Non-Small Cell Lung Carcinoma	disease	BEFREE;CTD_human
C0007133	Carcinoma, Papillary	disease	BEFREE
C0007134	Renal Cell Carcinoma	disease	BEFREE;CTD_human
C0007137	Squamous cell carcinoma	disease	BEFREE;LHGDN
C0007138	Carcinoma, Transitional Cell	disease	BEFREE
C0007273	Carotid Artery Diseases	group	CTD_human;LHGDN
C0008370	Cholestasis	disease	RGD
C0008625	Chromosome Aberrations	group	CTD_human
C0008626	Congenital chromosomal disease	group	BEFREE
C0008677	Bronchitis, Chronic	disease	BEFREE
C0009324	Ulcerative Colitis	disease	BEFREE
C0009402	Colorectal Carcinoma	disease	BEFREE
C0009404	Colorectal Neoplasms	group	BEFREE;LHGDN
C0010674	Cystic Fibrosis	disease	BEFREE;LHGDN
C0011615	Dermatitis, Atopic	disease	BEFREE;LHGDN
C0011616	Contact Dermatitis	disease	CTD_human
C0011847	Diabetes	disease	BEFREE
C0011849	Diabetes Mellitus	group	BEFREE;LHGDN
C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	BEFREE
C0013146	Drug abuse	disease	BEFREE
C0013182	Drug Allergy	phenotype	CTD_human
C0013404	Dyspnea	phenotype	BEFREE
C0013595	Eczema	disease	BEFREE
C0014170	Endometrial Neoplasms	group	LHGDN
C0014175	Endometriosis	disease	BEFREE;LHGDN
C0014859	Esophageal Neoplasms	group	BEFREE;LHGDN
C0014869	Peptic Esophagitis	disease	LHGDN
C0015397	Disorder of eye	group	BEFREE
C0015625	Fanconi Anemia	disease	BEFREE
C0015923	Fetal Alcohol Syndrome	disease	BEFREE
C0016034	Breast Fibrocystic Disease	disease	BEFREE
C0016059	Fibrosis	phenotype	LHGDN
C0016978	gallbladder neoplasm	disease	LHGDN
C0017601	Glaucoma	disease	BEFREE
C0017636	Glioblastoma	disease	BEFREE;LHGDN
C0017638	Glioma	disease	BEFREE;CTD_human
C0018621	Hay fever	disease	BEFREE
C0018671	Head and Neck Neoplasms	group	LHGDN
C0018790	Cardiac Arrest	disease	BEFREE
C0019158	Hepatitis	disease	BEFREE
C0019159	Hepatitis A	disease	BEFREE
C0019163	Hepatitis B	disease	BEFREE
C0019193	Hepatitis, Toxic	disease	CTD_human
C0019207	Hepatoma, Morris	disease	CTD_human
C0019208	Hepatoma, Novikoff	disease	CTD_human
C0019829	Hodgkin Disease	disease	BEFREE;CTD_human
C0020538	Hypertensive disease	group	BEFREE;CTD_human
C0021364	Male infertility	disease	BEFREE
C0022650	Kidney Calculi	disease	CTD_human
C0022658	Kidney Diseases	group	CTD_human
C0022660	Kidney Failure, Acute	disease	CTD_human
C0022661	Kidney Failure, Chronic	disease	LHGDN
C0023418	leukemia	disease	BEFREE
C0023434	Chronic Lymphocytic Leukemia	disease	LHGDN
C0023440	Acute Erythroblastic Leukemia	disease	BEFREE
C0023443	Hairy Cell Leukemia	disease	BEFREE
C0023449	Acute lymphocytic leukemia	disease	BEFREE
C0023452	Childhood Acute Lymphoblastic Leukemia	disease	BEFREE
C0023467	Leukemia, Myelocytic, Acute	disease	BEFREE
C0023473	Myeloid Leukemia, Chronic	disease	BEFREE;CTD_human
C0023530	Leukopenia	disease	BEFREE
C0023531	Leukoplakia	disease	BEFREE
C0023890	Liver Cirrhosis	disease	BEFREE
C0023891	Liver Cirrhosis, Alcoholic	disease	BEFREE
C0023892	Biliary cirrhosis	disease	LHGDN
C0023895	Liver diseases	group	BEFREE;LHGDN
C0023896	Alcoholic Liver Diseases	group	BEFREE
C0023904	Liver Neoplasms, Experimental	group	CTD_human
C0024115	Lung diseases	group	BEFREE
C0024117	Chronic Obstructive Airway Disease	disease	BEFREE;LHGDN
C0024121	Lung Neoplasms	group	BEFREE;CTD_human;CTD_mouse;LHGDN
C0024138	Lupus Erythematosus, Discoid	disease	BEFREE
C0024140	Lupus Erythematosus, Subacute Cutaneous	disease	BEFREE
C0024141	Lupus Erythematosus, Systemic	disease	BEFREE
C0024299	Lymphoma	group	BEFREE
C0024301	Lymphoma, Follicular	disease	BEFREE
C0024305	Lymphoma, Non-Hodgkin	disease	BEFREE;LHGDN
C0024530	Malaria	disease	BEFREE
C0024623	Malignant neoplasm of stomach	disease	BEFREE;CTD_human
C0025202	melanoma	disease	BEFREE;LHGDN
C0025267	Multiple Endocrine Neoplasia Type 1	disease	BEFREE
C0025286	Meningioma	disease	BEFREE
C0026470	Monoclonal Gammopathy of Undetermined Significance	disease	BEFREE
C0026618	Dental Fluorosis, Acquired	disease	BEFREE
C0026640	Mouth Neoplasms	group	LHGDN
C0026764	Multiple Myeloma	disease	BEFREE;LHGDN
C0027051	Myocardial Infarction	disease	BEFREE
C0027540	Necrosis	phenotype	CTD_human
C0027627	Neoplasm Metastasis	phenotype	BEFREE
C0027726	Nephrotic Syndrome	group	LHGDN
C0027809	Neurilemmoma	disease	BEFREE
C0027819	Neuroblastoma	group	BEFREE
C0027859	Acoustic Neuroma	disease	BEFREE
C0027947	Neutropenia	disease	BEFREE
C0028754	Obesity	disease	BEFREE
C0028945	oligodendroglioma	disease	LHGDN
C0028960	Oligospermia	disease	BEFREE
C0029463	Osteosarcoma	disease	BEFREE;CTD_human;LHGDN
C0029925	Ovarian Carcinoma	disease	BEFREE
C0030193	Pain	phenotype	BEFREE
C0030297	Pancreatic Neoplasm	disease	LHGDN
C0030305	Pancreatitis	disease	LHGDN
C0030554	Paresthesia	phenotype	BEFREE
C0030567	Parkinson Disease	disease	BEFREE;CTD_human
C0031117	Peripheral Neuropathy	group	BEFREE;CTD_human
C0031736	Polymorphous light eruption	disease	BEFREE
C0032000	Pituitary Adenoma	disease	BEFREE
C0032019	Pituitary Neoplasms	group	BEFREE;LHGDN
C0032230	Pleural Rub	phenotype	CTD_human
C0032285	Pneumonia	disease	BEFREE
C0032580	Adenomatous Polyposis Coli	disease	BEFREE
C0032914	Pre-Eclampsia	phenotype	LHGDN
C0032927	Precancerous Conditions	group	BEFREE;CTD_human
C0033036	Atrial Premature Complexes	disease	BEFREE
C0033578	Prostatic Neoplasms	group	BEFREE;CTD_human;LHGDN
C0033860	Psoriasis	disease	BEFREE
C0033937	Psychoses, Drug	disease	CTD_human
C0033941	Psychoses, Substance-Induced	disease	CTD_human
C0033975	Psychotic Disorders	group	BEFREE;PSYGENET
C0034067	Pulmonary Emphysema	disease	BEFREE
C0034642	Rales	phenotype	CTD_human
C0034885	Rectal Neoplasms	group	BEFREE
C0035204	Respiration Disorders	group	BEFREE
C0035234	Respiratory Sounds	phenotype	CTD_human
C0035243	Respiratory Tract Infections	group	BEFREE
C0035508	Rhonchi	phenotype	CTD_human
C0036341	Schizophrenia	disease	BEFREE;PSYGENET
C0036646	Age-related cataract	disease	BEFREE
C0036939	Shared Paranoid Disorder	disease	PSYGENET
C0037090	Signs and Symptoms, Respiratory	group	BEFREE
C0037116	Silicosis	disease	LHGDN
C0038356	Stomach Neoplasms	group	BEFREE;CTD_human;LHGDN
C0038450	Stridor	phenotype	CTD_human
C0039538	Teratoma	disease	BEFREE
C0039590	Testicular Neoplasms	group	LHGDN
C0040136	Thyroid Neoplasm	disease	LHGDN
C0040137	Thyroid Nodule	disease	BEFREE
C0042594	Vestibular Diseases	group	CTD_human
C0042900	Vitiligo	disease	BEFREE
C0042963	Vomiting	phenotype	BEFREE
C0043144	Wheezing	phenotype	BEFREE;CTD_human
C0079731	B-Cell Lymphomas	group	LHGDN
C0079744	Diffuse Large B-Cell Lymphoma	disease	BEFREE
C0079745	Lymphoma, Large-Cell, Follicular	disease	BEFREE
C0085129	Bronchial Hyperreactivity	disease	BEFREE
C0085605	Liver Failure	disease	BEFREE
C0085669	Acute leukemia	disease	BEFREE
C0085695	Chronic gastritis	disease	BEFREE
C0086404	Experimental Hepatoma	disease	CTD_human
C0086543	Cataract	disease	BEFREE
C0149782	Squamous cell carcinoma of lung	disease	BEFREE
C0149925	Small cell carcinoma of lung	disease	BEFREE
C0151517	Complete atrioventricular block	disease	BEFREE
C0151744	Myocardial Ischemia	disease	CTD_human
C0151779	Cutaneous Melanoma	disease	BEFREE
C0152013	Adenocarcinoma of lung (disorder)	disease	BEFREE
C0152018	Esophageal carcinoma	disease	BEFREE
C0152025	Polyneuropathy	disease	BEFREE
C0152266	Mixed Cellularity Hodgkin Lymphoma	disease	CTD_human
C0152267	Hodgkin lymphoma, lymphocyte depletion	disease	CTD_human
C0153381	Malignant neoplasm of mouth	disease	BEFREE
C0153382	Malignant neoplasm of oropharynx	disease	BEFREE
C0153405	Malignant neoplasm of pharynx	disease	BEFREE
C0153594	Malignant neoplasm of testis	disease	BEFREE
C0153633	Malignant neoplasm of brain	disease	BEFREE
C0154088	Carcinoma in situ of prostate	disease	RGD
C0155626	Acute myocardial infarction	disease	BEFREE
C0155877	Allergic asthma	disease	BEFREE
C0162309	Adrenoleukodystrophy	disease	BEFREE
C0162351	Contact hypersensitivity	phenotype	CTD_human
C0175754	Agenesis of corpus callosum	disease	BEFREE
C0178874	Tumor Progression	phenotype	BEFREE
C0205696	Anaplastic carcinoma	disease	CTD_human
C0205697	Carcinoma, Spindle-Cell	disease	CTD_human
C0205698	Undifferentiated carcinoma	phenotype	CTD_human
C0205699	Carcinomatosis	phenotype	CTD_human
C0205944	Sarcoma, Epithelioid	disease	CTD_human
C0205945	Sarcoma, Spindle Cell	disease	CTD_human
C0206659	Embryonal Carcinoma	disease	BEFREE
C0206698	Cholangiocarcinoma	disease	BEFREE
C0220597	Adult Hodgkin Lymphoma	disease	CTD_human
C0220612	Childhood Non-Hodgkin Lymphoma	disease	BEFREE
C0220615	Adult Acute Myeloblastic Leukemia	disease	BEFREE
C0220620	Gastrointestinal Carcinoid Tumor	disease	BEFREE
C0220624	Adult Brain Neoplasm	disease	BEFREE
C0220641	Lip and Oral Cavity Carcinoma	disease	BEFREE
C0221757	alpha 1-Antitrypsin Deficiency	disease	BEFREE
C0235874	Disease Exacerbation	phenotype	CTD_human
C0235974	Pancreatic carcinoma	disease	BEFREE
C0236733	Amphetamine-Related Disorders	group	CTD_human
C0236804	Amphetamine Addiction	disease	CTD_human
C0236807	Amphetamine Abuse	disease	CTD_human
C0238033	Carcinoma of Male Breast	disease	BEFREE
C0238462	Medullary carcinoma of thyroid	disease	BEFREE
C0242379	Malignant neoplasm of lung	disease	BEFREE;CTD_human;CTD_mouse
C0242383	Age related macular degeneration	disease	BEFREE;LHGDN
C0242422	Parkinsonian Disorders	group	BEFREE
C0242647	Mucosa-Associated Lymphoid Tissue Lymphoma	disease	BEFREE
C0242787	Malignant neoplasm of male breast	disease	BEFREE
C0259783	mixed gliomas	disease	CTD_human
C0262584	Carcinoma, Small Cell	disease	BEFREE
C0264408	Childhood asthma	disease	BEFREE
C0264423	Asthma, Occupational	disease	BEFREE
C0267809	Cirrhosis, Cryptogenic	disease	BEFREE
C0268138	Xeroderma Pigmentosum, Complementation Group D	disease	BEFREE
C0268398	Familial lichen amyloidosis	disease	BEFREE
C0270736	Essential Tremor	disease	BEFREE;CTD_human
C0271160	Cortical cataract	phenotype	BEFREE
C0278510	Childhood Medulloblastoma	disease	BEFREE
C0278996	Malignant Head and Neck Neoplasm	disease	BEFREE
C0279626	Squamous cell carcinoma of esophagus	disease	BEFREE
C0279628	Adenocarcinoma Of Esophagus	disease	BEFREE
C0279680	Transitional cell carcinoma of bladder	disease	BEFREE
C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	CTD_human
C0280100	Solid Neoplasm	phenotype	BEFREE
C0280280	stage, prostate cancer	disease	BEFREE
C0280313	Squamous cell carcinoma of oropharynx	disease	BEFREE
C0280788	Anaplastic Ependymoma	disease	BEFREE
C0282160	Aplasia Cutis Congenita	disease	BEFREE
C0282313	Condition, Preneoplastic	phenotype	CTD_human
C0282612	Prostatic Intraepithelial Neoplasias	disease	BEFREE;CTD_human;LHGDN
C0333641	Atrophic	phenotype	LHGDN
C0334579	Anaplastic astrocytoma	disease	BEFREE
C0334619	HODGKIN'S AND NON-HODGKIN'S LYMPHOMA	disease	BEFREE
C0334634	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	disease	LHGDN
C0339143	Thyroid associated opthalmopathies	disease	BEFREE
C0339573	Glaucoma, Primary Open Angle	disease	BEFREE
C0340100	High altitude pulmonary edema	disease	BEFREE
C0340170	Complicated pneumoconiosis	disease	BEFREE
C0345904	Malignant neoplasm of liver	disease	BEFREE
C0345905	Intrahepatic Cholangiocarcinoma	disease	BEFREE
C0345967	Malignant mesothelioma	disease	BEFREE
C0346153	Breast Cancer, Familial	disease	BEFREE
C0346647	Malignant neoplasm of pancreas	disease	BEFREE
C0346957	Disseminated Malignant Neoplasm	phenotype	BEFREE
C0349204	Nonorganic psychosis	disease	BEFREE;PSYGENET
C0369183	Erythrocyte Mean Corpuscular Hemoglobin Test	phenotype	GWASDB
C0376358	Malignant neoplasm of prostate	disease	BEFREE;CTD_human
C0392514	Hereditary hemochromatosis	disease	BEFREE
C0393554	Amyotrophic Lateral Sclerosis With Dementia	disease	CTD_human
C0393615	Familial Tremor	disease	CTD_human
C0400966	Non-alcoholic Fatty Liver Disease	disease	BEFREE;CTD_human
C0403447	Chronic Kidney Insufficiency	disease	BEFREE
C0409974	Lupus Erythematosus	disease	BEFREE
C0424295	Hyperactive behavior	phenotype	BEFREE
C0432252	Osteoporosis with pseudoglioma	disease	BEFREE
C0442874	Neuropathy	group	BEFREE
C0476089	Endometrial Carcinoma	disease	BEFREE
C0524909	Hepatitis B, Chronic	disease	BEFREE;LHGDN
C0543859	Amyotrophic Lateral Sclerosis, Guam Form	disease	CTD_human
C0546837	Malignant neoplasm of esophagus	disease	BEFREE
C0549473	Thyroid carcinoma	disease	BEFREE
C0555198	Malignant Glioma	disease	CTD_human
C0565599	Maternal hypertension	disease	BEFREE
C0577631	Carotid Atherosclerosis	disease	BEFREE;CTD_human
C0585442	Osteosarcoma of bone	disease	BEFREE
C0595989	Carcinoma of larynx	disease	BEFREE
C0596263	Carcinogenesis	phenotype	BEFREE
C0598766	Leukemogenesis	disease	BEFREE
C0600139	Prostate carcinoma	disease	BEFREE
C0600178	External Carotid Artery Diseases	group	CTD_human
C0600427	Cocaine Dependence	disease	BEFREE;PSYGENET
C0677886	Epithelial ovarian cancer	disease	BEFREE
C0677944	Sentinel node (disorder)	disease	BEFREE
C0678222	Breast Carcinoma	disease	BEFREE;CTD_human
C0684249	Carcinoma of lung	disease	BEFREE
C0686619	Secondary malignant neoplasm of lymph node	disease	BEFREE
C0699790	Colon Carcinoma	disease	BEFREE
C0699791	Stomach Carcinoma	disease	BEFREE
C0699885	Carcinoma of bladder	disease	BEFREE
C0699893	Skin carcinoma	disease	BEFREE
C0700095	Central neuroblastoma	disease	BEFREE
C0730362	Disorder of macula of retina	group	BEFREE
C0740858	Substance abuse problem	disease	BEFREE
C0750986	Internal Carotid Artery Diseases	disease	CTD_human
C0750987	Arterial Diseases, Common Carotid	disease	CTD_human
C0751569	Genitourinary Cancer	disease	BEFREE
C0810364	Cleft Lip with or without Cleft Palate	disease	BEFREE
C0850572	Adenomatous polyp of colon	disease	BEFREE
C0850639	premalignant lesion	phenotype	BEFREE
C0850666	Infection caused by Helicobacter pylori	disease	BEFREE
C0853879	Invasive carcinoma of breast	disease	BEFREE
C0855197	Malignant Testicular Germ Cell Tumor	disease	BEFREE
C0860207	Drug-Induced Liver Disease	disease	BEFREE;CTD_human
C0919267	ovarian neoplasm	disease	BEFREE;LHGDN
C0940937	precancerous lesions	phenotype	BEFREE
C0948089	Acute Coronary Syndrome	disease	CTD_human
C0948380	Colorectal cancer metastatic	disease	BEFREE
C0949059	Polyp of large intestine	disease	BEFREE
C1112160	Gastrooesophageal cancer	disease	BEFREE
C1134719	Invasive Ductal Breast Carcinoma	disease	BEFREE
C1140680	Malignant neoplasm of ovary	disease	BEFREE
C1167791	Skin toxicity	disease	BEFREE
C1168327	High-Grade Prostatic Intraepithelial Neoplasia	disease	BEFREE
C1168401	Squamous cell carcinoma of the head and neck	disease	BEFREE
C1257931	Mammary Neoplasms, Human	group	CTD_human
C1258085	Barrett Epithelium	disease	BEFREE
C1261473	Sarcoma	group	BEFREE;CTD_human
C1261502	Finding of Mean Corpuscular Hemoglobin	phenotype	GWASDB
C1262760	Hepatitis, Drug-Induced	disease	CTD_human
C1266042	Chromophobe Renal Cell Carcinoma	disease	CTD_human
C1266043	Sarcomatoid Renal Cell Carcinoma	disease	CTD_human
C1266044	Collecting Duct Carcinoma of the Kidney	disease	CTD_human
C1266194	Lymphocyte Rich Classical Hodgkin Lymphoma	disease	CTD_human
C1275122	Familial multiple trichoepitheliomata	disease	BEFREE
C1302401	Adenoma of large intestine	disease	BEFREE
C1302547	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	disease	BEFREE
C1306460	Primary malignant neoplasm of lung	disease	BEFREE
C1306837	Papillary Renal Cell Carcinoma	disease	BEFREE;CTD_human
C1328504	Hormone refractory prostate cancer	disease	BEFREE
C1332977	Childhood Leukemia	disease	BEFREE
C1333763	Gastric Cardia Carcinoma	disease	BEFREE
C1333782	Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	disease	BEFREE
C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	BEFREE
C1334968	Nodular Lymphocyte Predominant Hodgkin Lymphoma	disease	CTD_human
C1335302	Pancreatic Ductal Adenocarcinoma	disease	BEFREE
C1336076	Sporadic Breast Carcinoma	disease	BEFREE
C1336708	Testicular Germ Cell Tumor	disease	BEFREE
C1336735	Treatment related acute myeloid leukaemia	disease	BEFREE
C1367654	Marginal Zone B-Cell Lymphoma	disease	BEFREE
C1378703	Renal carcinoma	disease	BEFREE
C1449563	Cardiomyopathy, Familial Idiopathic	disease	BEFREE
C1456865	Ureteral Calculi	disease	CTD_human
C1458155	Mammary Neoplasms	group	CTD_human;LHGDN
C1510586	Autism Spectrum Disorders	disease	BEFREE
C1512409	Hepatocarcinogenesis	disease	BEFREE
C1518005	Low Grade Cervical Squamous Intraepithelial Neoplasia	disease	BEFREE
C1527249	Colorectal Cancer	disease	BEFREE
C1561643	Chronic Kidney Diseases	group	BEFREE
C1565662	Acute Kidney Insufficiency	disease	CTD_human
C1623038	Cirrhosis	disease	BEFREE
C1704272	Benign Prostatic Hyperplasia	disease	BEFREE
C1708349	Hereditary Diffuse Gastric Cancer	disease	CTD_human
C1739363	Prostatic Hypertrophy	disease	RGD
C1827377	Slow acetylator due to N-acetyltransferase enzyme variant	disease	BEFREE
C1847835	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	disease	BEFREE
C1850900	Familial primary gastric lymphoma	disease	BEFREE
C1861305	TARSAL-CARPAL COALITION SYNDROME	disease	BEFREE
C1883486	Uterine Corpus Cancer	disease	BEFREE
C1956346	Coronary Artery Disease	disease	BEFREE
C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	BEFREE;LHGDN
C2145472	Urothelial Carcinoma	disease	BEFREE
C2216702	malignant neoplasm of breast staging	disease	BEFREE
C2239176	Liver carcinoma	disease	BEFREE;CTD_human;LHGDN
C2349952	Oropharyngeal Carcinoma	disease	BEFREE
C2609414	Acute kidney injury	disease	CTD_human
C2931822	Nasopharyngeal carcinoma	disease	BEFREE
C2986665	Early-Stage Breast Carcinoma	disease	BEFREE
C3241937	Nonalcoholic Steatohepatitis	disease	CTD_human
C3273239	Proliferative Inflammatory Atrophy	disease	BEFREE
C3463824	MYELODYSPLASTIC SYNDROME	group	BEFREE
C3469186	HEMOCHROMATOSIS, TYPE 1	disease	BEFREE
C3539909	Allergic disposition	phenotype	BEFREE
C3642345	Luminal A Breast Carcinoma	disease	BEFREE
C3642346	Luminal B Breast Carcinoma	disease	BEFREE
C3658290	Drug-Induced Acute Liver Injury	disease	CTD_human
C3662483	Allergic sensitization	disease	BEFREE
C3714514	Infection	group	LHGDN
C3805278	Extrahepatic Cholangiocarcinoma	disease	BEFREE
C3811653	Experimental Organism Basal Cell Carcinoma	phenotype	BEFREE
C3850141	Acute-On-Chronic Liver Failure	disease	BEFREE
C4048328	cervical cancer	disease	BEFREE
C4277682	Chemical and Drug Induced Liver Injury	disease	CTD_human
C4279912	Chemically-Induced Liver Toxicity	disease	CTD_human

Gene Ontology (GO)/biological pathways

GO:Molecular Function

GO ID	GO Term	Evidence
GO:0004364	glutathione transferase activity	IDA
GO:0004364	glutathione transferase activity	IBA
GO:0004602	glutathione peroxidase activity	IDA
GO:0005515	protein binding	IPI
GO:0008144	drug binding	IEA
GO:0008432	JUN kinase binding	ISS
GO:0019207	kinase regulator activity	ISS
GO:0035730	S-nitrosoglutathione binding	IDA
GO:0035731	dinitrosyl-iron complex binding	IDA
GO:0043295	glutathione binding	IEA
GO:0070026	nitric oxide binding	NAS

GO:Biological Process

GO ID	GO Term	Evidence
GO:0000302	response to reactive oxygen species	ISS
GO:0002674	negative regulation of acute inflammatory response	NAS
GO:0006469	negative regulation of protein kinase activity	IDA
GO:0006749	glutathione metabolic process	IDA
GO:0006749	glutathione metabolic process	IBA
GO:0006805	xenobiotic metabolic process	IDA
GO:0007417	central nervous system development	TAS
GO:0009890	negative regulation of biosynthetic process	IDA
GO:0010804	negative regulation of tumor necrosis factor-mediated signaling pathway	IC
GO:0014003	oligodendrocyte development	IEA
GO:0031100	animal organ regeneration	IEA
GO:0032355	response to estradiol	IEA
GO:0032691	negative regulation of interleukin-1 beta production	IDA
GO:0032720	negative regulation of tumor necrosis factor production	IDA
GO:0032869	cellular response to insulin stimulus	IEA
GO:0032872	regulation of stress-activated MAPK cascade	ISS
GO:0032873	negative regulation of stress-activated MAPK cascade	ISS
GO:0032930	positive regulation of superoxide anion generation	ISS
GO:0033591	response to L-ascorbic acid	IEA
GO:0034599	cellular response to oxidative stress	TAS
GO:0035726	common myeloid progenitor cell proliferation	ISS
GO:0035732	nitric oxide storage	NAS
GO:0043066	negative regulation of apoptotic process	TAS
GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	ISS
GO:0043200	response to amino acid	IEA
GO:0043312	neutrophil degranulation	TAS
GO:0043407	negative regulation of MAP kinase activity	IDA
GO:0043409	negative regulation of MAPK cascade	NAS
GO:0043508	negative regulation of JUN kinase activity	IDA
GO:0043651	linoleic acid metabolic process	IDA
GO:0045471	response to ethanol	IEA
GO:0048147	negative regulation of fibroblast proliferation	ISS
GO:0051771	negative regulation of nitric-oxide synthase biosynthetic process	IDA
GO:0070372	regulation of ERK1 and ERK2 cascade	ISS
GO:0070373	negative regulation of ERK1 and ERK2 cascade	IDA
GO:0070664	negative regulation of leukocyte proliferation	ISS
GO:0071222	cellular response to lipopolysaccharide	ISS
GO:0071364	cellular response to epidermal growth factor stimulus	IEA
GO:0071385	cellular response to glucocorticoid stimulus	IEA
GO:0071460	cellular response to cell-matrix adhesion	IEA
GO:0071638	negative regulation of monocyte chemotactic protein-1 production	IDA
GO:0071672	negative regulation of smooth muscle cell chemotaxis	IEA
GO:0098869	cellular oxidant detoxification	IEA
GO:1901687	glutathione derivative biosynthetic process	TAS
GO:1904706	negative regulation of vascular smooth muscle cell proliferation	IEA
GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	IDA

GO:Cellular Component

GO ID	GO Term	Evidence
GO:0005576	extracellular region	TAS
GO:0005615	extracellular space	HDA
GO:0005634	nucleus	IEA
GO:0005737	cytoplasm	TAS
GO:0005739	mitochondrion	IDA
GO:0005829	cytosol	IDA
GO:0005829	cytosol	IBA
GO:0005829	cytosol	TAS
GO:0005886	plasma membrane	IEA
GO:0031982	vesicle	HDA
GO:0034774	secretory granule lumen	TAS
GO:0070062	extracellular exosome	HDA
GO:0097057	TRAF2-GSTP1 complex	IDA
GO:1904813	ficolin-1-rich granule lumen	TAS

Reactome Pathway

Reactome ID	Reactome Term	Evidence
R-HSA-1430728	Metabolism	TAS
R-HSA-156580	Phase II - Conjugation of compounds	TAS
R-HSA-156590	Glutathione conjugation	TAS
R-HSA-168249	Innate Immune System	TAS
R-HSA-168256	Immune System	TAS
R-HSA-211859	Biological oxidations	TAS
R-HSA-2262752	Cellular responses to stress	TAS
R-HSA-3299685	Detoxification of Reactive Oxygen Species	TAS
R-HSA-6798695	Neutrophil degranulation	TAS
R-HSA-8953897	Cellular responses to external stimuli	TAS

Drugs and compounds information

ID	Drug Name	Action	PubMed
C026486	1,2,5,6-dibenzanthracene	1,2,5,6-dibenzanthracene results in decreased expression of GSTP1 mRNA	26377693
C007318	1,2-dibromo-3-chloropropane	GSTP1 protein affects the metabolism of 1,2-dibromo-3-chloropropane	8242859
C007318	1,2-dibromo-3-chloropropane	GSTP1 protein results in increased susceptibility to 1,2-dibromo-3-chloropropane	8242859
C049325	1,2-dithiol-3-thione	1,2-dithiol-3-thione results in increased expression of GSTP1 mRNA	19162173; 19695238;
C031763	1,3-butadiene	1,3-butadiene results in increased expression of GSTP1 mRNA	29038090
C028474	1,4-bis(2-(3,5-dichloropyridyloxy))benzene	1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GSTP1 mRNA	18692084
C097240	15-deoxy-delta(12,14)-prostaglandin J2	15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 mRNA	11600134
C097240	15-deoxy-delta(12,14)-prostaglandin J2	15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 protein	11600134
C097240	15-deoxy-delta(12,14)-prostaglandin J2	Soybean Oil promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 mRNA]	11600134
C097240	15-deoxy-delta(12,14)-prostaglandin J2	Soybean Oil promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 protein]	11600134
C118559	1-bromopropane	1-bromopropane results in increased expression of GSTP1 protein	21925529
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Amphotericin B inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Anthralin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Atovaquone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Aurothioglucose inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	avobenzone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	betamethasone-17,21-dipropionate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	bromindione inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	chloramphenicol palmitate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Chlorophyllides inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Chlorotrianisene inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Chlortetracycline inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Clofazimine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Clotrimazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	cobamamide inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Dienestrol inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Diethylstilbestrol inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Doxycycline inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Econazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Enoxacin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Equilin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Ergotamine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Erythrosine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	estradiol 17 beta-cypionate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Estradiol analog inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Estradiol inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Ethacrynic Acid inhibits the reaction [Chlorophyllides inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Ethacrynic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Fenbendazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Fenofibrate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Flufenamic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Flunarizine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Fluocinonide inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Flurothyl inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Flutamide inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Folic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Gentian Violet inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Gramicidin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	halazone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Hexachlorophene inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	homosalate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Hydroxyzine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Iodoquinol inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Itraconazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Lansoprazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Mebendazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Meclizine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Melphalan inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Merbromin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Methylene Blue inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Mitomycin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Mitotane inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Nifedipine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Nisoldipine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Nitrendipine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	oxibendazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	oxiconazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Oxyphenbutazone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	pararosaniline inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Phenolphthalein inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Phenoxybenzamine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Phenylbutazone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Pyrantel Pamoate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	sanguinarine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Simvastatin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	sulconazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Temefos inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Teniposide inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Terbinafine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Testosterone Propionate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Thiostrepton inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Tolnaftate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	tranilast inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Vitamin A inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	Vitamin K 1 inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042630	1-chloro-2,4-dinitrobenzene-glutathione conjugate	GSTP1 protein affects the metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate	11684093
C033146	1-hydroxypyrene	GSTP1 gene polymorphism results in decreased secretion of 1-hydroxypyrene	21787681
D015058	1-Naphthylisothiocyanate	1-Naphthylisothiocyanate results in increased expression of GSTP1 mRNA	15913567
D015058	1-Naphthylisothiocyanate	1-Naphthylisothiocyanate results in increased expression of GSTP1 mRNA	20551477
C016614	1-nitronaphthalene	1-nitronaphthalene metabolite binds to GSTP1 protein	16453347
C024336	1-phenylazo-2-naphthol	1-phenylazo-2-naphthol results in increased expression of GSTP1 mRNA	2563599
C477694	2,2',4,4',5-brominated diphenyl ether	2,2',4,4',5-brominated diphenyl ether results in decreased expression of GSTP1 protein	19954255
C477694	2,2',4,4',5-brominated diphenyl ether	2,2',4,4',5-brominated diphenyl ether results in increased expression of GSTP1 protein	19954255
C511295	2,2',4,4'-tetrabromodiphenyl ether	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of GSTP1 mRNA	22546086
C029141	2,2,5,7,8-pentamethyl-1-hydroxychroman	2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of GSTP1 mRNA	21920950
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Decitabine results in increased expression of GSTP1 protein]	19396019
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of GSTP1 protein	19396019
C070055	2,3',4,4',5-pentachlorobiphenyl	2,3',4,4',5-pentachlorobiphenyl results in increased expression of GSTP1 mRNA	31388691
C014211	2,3,7,8-tetrachlorodibenzofuran	2,3,7,8-tetrachlorodibenzofuran affects the expression of GSTP1 mRNA	18343893; 20702594;
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of GSTP1 protein]]	25271104
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased expression of GSTP1 protein]	25271104; 26577515;
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of GSTP1 mRNA	22406437
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of GSTP1 mRNA	22406437
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of GSTP1 protein	22406437
C009497	2-(4-toluidino)-6-naphthalenesulfonic acid	2-(4-toluidino)-6-naphthalenesulfonic acid binds to GSTP1 protein	7725348
C009407	2,5,2',5'-tetrachlorobiphenyl	2,5,2',5'-tetrachlorobiphenyl results in increased expression of GSTP1 mRNA	21703328
C543308	2,5-dimethyl-1,4-benzoquinonediamine	2,5-dimethyl-1,4-benzoquinonediamine binds to and results in increased metabolism of GSTP1 protein	19469519
C019359	2,5-di-tert-butylhydroquinone	2,5-di-tert-butylhydroquinone results in increased expression of GSTP1 protein	12680784
C011269	2,5-hexanedione	2,5-hexanedione results in decreased expression of GSTP1 mRNA	16141653
C024709	2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone	2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to GSTP1 protein	16533022
C024709	2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone	2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone results in increased alkylation of and results in decreased activity of GSTP1 protein	15606144
C096092	2-(acetoxyamino)-1-methyl-6-phenylimidazo(4,5-b)pyridine	GSTP1 protein affects the metabolism of and results in decreased activity of 2-(acetoxyamino)-1-methyl-6-phenylimidazo(4,5-b)pyridine	8069858
D015073	2-Acetylaminofluorene	[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein	18271918
D015073	2-Acetylaminofluorene	2-Acetylaminofluorene results in increased expression of GSTP1 mRNA	21785164; 22213190;
D015073	2-Acetylaminofluorene	2-Acetylaminofluorene results in increased expression of GSTP1 protein	21785164
D015073	2-Acetylaminofluorene	Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein]	15554553
D015073	2-Acetylaminofluorene	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein	15554553
D015073	2-Acetylaminofluorene	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA	12497209; 12781041;
D015073	2-Acetylaminofluorene	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein	12497209; 12781041; 17393424;
D015073	2-Acetylaminofluorene	herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA]	12907702
D015073	2-Acetylaminofluorene	herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein]	12907702
D015073	2-Acetylaminofluorene	Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA]	12497209
D015073	2-Acetylaminofluorene	Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein]	12497209
D015073	2-Acetylaminofluorene	Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein]	15554553
C099328	2-allylphenol	2-allylphenol results in decreased activity of GSTP1 protein	8620581
C502239	2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct	[GSTP1 protein co-treated with Glutathione] inhibits the reaction [[Adenosine Triphosphate results in increased metabolism of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased abundance of 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct]	11196146
C502239	2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct	GSTP1 protein results in decreased abundance of 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct	11196146
C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	GSTP1 protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	19223546
C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of GSTP1 protein	22581815
C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dietary Fats] results in decreased expression of GSTP1 mRNA	12097258
C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline	GSTP1 protein affects the susceptibility to 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline	19223546
C035208	2-amino-4,6-dinitrotoluene	2-amino-4,6-dinitrotoluene affects the expression of GSTP1 mRNA	21346803
C012177	2-aminofluorene	2-aminofluorene promotes the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	19052882
C012177	2-aminofluorene	2-aminofluorene results in increased expression of GSTP1 protein	19052882
C012796	2-butenal	2-butenal binds to and results in decreased activity of GSTP1 protein	9463521
C012796	2-butenal	GSTP1 protein results in increased metabolism of 2-butenal	10799737
C012796	2-butenal	2-butenal results in increased expression of GSTP1 protein	11600134
C031278	2-chloroethyl ethyl sulfide	2-chloroethyl ethyl sulfide results in increased expression of GSTP1 mRNA	20382172
C004726	2-dichlorobenzene	2-dichlorobenzene affects the localization of GSTP1 protein	18409811
C004726	2-dichlorobenzene	2-dichlorobenzene results in decreased activity of GSTP1 protein	18409811
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP1A1 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP1A2 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP1B1 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP2A6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP2B6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP2C18 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP2C19 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP2C8 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP2E1 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP2J2 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	[CYP3A5 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
C586542	2'-(glutathion-S-yl)-deschlorodiclofenac	Ketoconazole inhibits the reaction [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac]	24246759
C011917	2-heptanone	2-heptanone results in decreased activity of GSTP1 protein	18409811
C051750	2-hexenal	2-hexenal binds to and results in decreased activity of GSTP1 protein	9463521
C060533	2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine	[GSTP1 protein co-treated with Glutathione] inhibits the reaction [Adenosine Triphosphate results in increased activity of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine]	11196146
C060533	2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine	[GSTP1 protein co-treated with Glutathione] inhibits the reaction [[Adenosine Triphosphate results in increased metabolism of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased abundance of 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct]	11196146
C060533	2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine	GSTP1 protein results in decreased susceptibility to 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine	11196146
C060533	2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine	2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of GSTP1 protein	17122891
C019499	2-nitrofluorene	2-nitrofluorene results in increased expression of GSTP1 mRNA	23052194
C029536	2-oxothiazolidine-4-carboxylic acid	2-oxothiazolidine-4-carboxylic acid results in increased expression of and results in increased activity of GSTP1 protein	16950796
C082398	2-S-glutathionylcaffeic acid	2-S-glutathionylcaffeic acid results in decreased activity of GSTP1 protein	8340025
C018855	2-tert-butylhydroquinone	2-tert-butylhydroquinone results in increased expression of GSTP1 mRNA	17961207
C018855	2-tert-butylhydroquinone	2-tert-butylhydroquinone results in increased expression of GSTP1 mRNA	15533597
C018855	2-tert-butylhydroquinone	2-tert-butylhydroquinone results in increased expression of GSTP1 protein	12680784
C018855	2-tert-butylhydroquinone	2-tert-butylhydroquinone results in increased expression of GSTP1	22174413
C018855	2-tert-butylhydroquinone	NFE2L2A affects the reaction [2-tert-butylhydroquinone results in increased expression of GSTP1]	22174413
C023035	3,4,5,3',4'-pentachlorobiphenyl	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GSTP1 mRNA	30823661
D015102	3,4-Dihydroxyphenylacetic Acid	3,4-Dihydroxyphenylacetic Acid results in increased expression of GSTP1 mRNA	19743802
C017906	3-dinitrobenzene	3-dinitrobenzene results in increased expression of GSTP1 mRNA	21983209
C527796	3-morpholinopropyl isothiocyanate	3-morpholinopropyl isothiocyanate results in increased expression of GSTP1 mRNA	20498004
C527796	3-morpholinopropyl isothiocyanate	3-morpholinopropyl isothiocyanate results in increased expression of GSTP1 protein	20498004
C015392	3-nitropropionic acid	[naringin co-treated with 3-nitropropionic acid] results in increased expression of GSTP1 mRNA	22871521
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA	27188386
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA	27188386
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA	27188386
C035207	4-amino-2,6-dinitrotoluene	4-amino-2,6-dinitrotoluene affects the expression of GSTP1 mRNA	21346803
C010407	4-chloronitrobenzene	GSTP1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione]	8973562
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal analog binds to GSTP1	18232660
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal binds to and results in decreased activity of GSTP1 protein	9463521
C027576	4-hydroxy-2-nonenal	GSTP1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal	15829614
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal results in increased expression of GSTP1 mRNA	19191707
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal results in decreased expression of GSTP1 protein	20570720
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal results in increased expression of GSTP1 protein	11600134
C027576	4-hydroxy-2-nonenal	Glutathione inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of GSTP1 protein]	20570720
C108036	4'-hydroxydiclofenac	[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac	24246759
C108036	4'-hydroxydiclofenac	[[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac	24246759
C108036	4'-hydroxydiclofenac	[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac	24246759
C108036	4'-hydroxydiclofenac	[[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac	24246759
C108036	4'-hydroxydiclofenac	GSTP1 protein results in increased glutathionylation of 4'-hydroxydiclofenac	24552538
C108036	4'-hydroxydiclofenac	NQO1 protein inhibits the reaction [GSTP1 protein results in increased glutathionylation of 4'-hydroxydiclofenac]	24552538
C108036	4'-hydroxydiclofenac	Sulfaphenazole inhibits the reaction [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac]	24246759
C027562	4-nitrobenzyl chloride	GSTP1 protein affects the metabolism of 4-nitrobenzyl chloride	3592675
C008642	4-nitrophenyl acetate	GSTP1 protein affects the metabolism of 4-nitrophenyl acetate	3592675
C403894	4-oxo-2-nonenal	GSTP1 protein affects the metabolism of [4-oxo-2-nonenal co-treated with Glutathione]	15528046
C029728	4-phenylenediamine	4-phenylenediamine results in increased metabolism of GSTP1 protein	19469519
C099327	4-propylphenol	4-propylphenol results in decreased activity of GSTP1 protein	8620581
C029370	4-toluidine	4-toluidine results in increased expression of GSTP1 mRNA	27638505
C012606	4-vinyl-1-cyclohexene dioxide	4-vinyl-1-cyclohexene dioxide results in increased expression of GSTP1 mRNA	20542051
C012606	4-vinyl-1-cyclohexene dioxide	4-vinyl-1-cyclohexene dioxide results in increased expression of GSTP1 protein	20542051
C029351	4-vinylpyridine	GSTP1 protein affects the metabolism of 4-vinylpyridine	15882759
C522589	5,6-dihydrocyclopenta-1,2-dithiole-3-thione	5,6-dihydrocyclopenta-1,2-dithiole-3-thione results in increased expression of GSTP1 mRNA	19695238
C117715	5-hydroxydiclofenac	[CYP2B6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
C117715	5-hydroxydiclofenac	[CYP2C18 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
C117715	5-hydroxydiclofenac	[CYP2C19 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
C117715	5-hydroxydiclofenac	[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
C117715	5-hydroxydiclofenac	[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
C117715	5-hydroxydiclofenac	[[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 5-hydroxydiclofenac	24246759
C117715	5-hydroxydiclofenac	[CYP3A5 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
C117715	5-hydroxydiclofenac	Ketoconazole inhibits the reaction [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac]	24246759
C086396	5-S-glutathionyl-alpha-methyldopa	5-S-glutathionyl-alpha-methyldopa results in decreased activity of GSTP1 protein	8131222
C086394	5-S-glutathionyldopamine	5-S-glutathionyldopamine results in decreased activity of GSTP1 protein	8131222
C528479	6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol	6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol results in decreased activity of GSTP1 protein	29667773
C122155	6-bromoacetyl-2-dimethylaminonaphthalene	GSTP1 protein affects the metabolism of [6-bromoacetyl-2-dimethylaminonaphthalene co-treated with Glutathione]	12470677
C478192	6-chloroacetyl-2-dimethylaminonaphthalene	GSTP1 protein affects the metabolism of 6-chloroacetyl-2-dimethylaminonaphthalene	12470677
C111984	6-methylsulfinylhexyl isothiocyanate	6-methylsulfinylhexyl isothiocyanate results in increased expression of GSTP1 protein	11706044
C077646	7,12-benz(a)anthraquinone	7,12-benz(a)anthraquinone results in increased expression of GSTP1 mRNA	23684558
D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	GSTP1 protein affects the metabolism of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione]	9403173
D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	GSTP1 protein affects the metabolism of and results in decreased activity of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione]	11849043
C008450	7-methylguanine	GSTP1 gene polymorphism affects the susceptibility to and affects the metabolism of 7-methylguanine	15066569
C529431	8-2 fluorotelomer alcohol	8-2 fluorotelomer alcohol results in increased expression of GSTP1 mRNA	21984479
D015127	9,10-Dimethyl-1,2-benzanthracene	9,10-Dimethyl-1,2-benzanthracene results in increased expression of GSTP1 mRNA	21294050
D015127	9,10-Dimethyl-1,2-benzanthracene	Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GSTP1 mRNA]	21294050
D015127	9,10-Dimethyl-1,2-benzanthracene	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSTP1 mRNA	12097258
D015127	9,10-Dimethyl-1,2-benzanthracene	9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of GSTP1 protein	22406437
D015127	9,10-Dimethyl-1,2-benzanthracene	9,10-Dimethyl-1,2-benzanthracene results in increased expression of GSTP1 mRNA	12097258; 22406437; 24576726;
D015127	9,10-Dimethyl-1,2-benzanthracene	GSTP1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene	22406437
D000082	Acetaminophen	Acetaminophen affects the expression of GSTP1 mRNA	25064622
D000082	Acetaminophen	Acetaminophen metabolite binds to GSTP1 protein	21639118
D000082	Acetaminophen	GSTP1 protein results in decreased susceptibility to Acetaminophen	22022436
D000082	Acetaminophen	Acetaminophen affects the expression of GSTP1 mRNA	17562736
D000082	Acetaminophen	Acetaminophen results in decreased expression of GSTP1 mRNA	16611625
D000082	Acetaminophen	[Clofibrate co-treated with Acetaminophen] affects the expression of GSTP1 mRNA	17585979
D000082	Acetaminophen	[CTH gene mutant form results in increased susceptibility to Acetaminophen] which results in decreased expression of GSTP1 protein	25499718
D000082	Acetaminophen	PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GSTP1 mRNA]	17585979
D000082	Acetaminophen	SLC13A1 protein affects the reaction [Acetaminophen results in increased expression of GSTP1 mRNA]	16729303
D000082	Acetaminophen	Acetaminophen results in increased expression of GSTP1 mRNA	11779202; 30723492;
D000108	Acetylcarnitine	Acetylcarnitine affects the reaction [Dexamethasone results in decreased expression of GSTP1 mRNA]	21986892
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA]	22129741
D015250	Aclarubicin	Aclarubicin promotes the reaction [GATA1 protein binds to GSTP1 promoter]	14623254
D015250	Aclarubicin	Aclarubicin results in increased expression of GSTP1 mRNA	14623254
D015250	Aclarubicin	Aclarubicin results in increased expression of GSTP1 protein	14623254
D000165	Acridine Orange	[Acridine Orange binds to Platinum Compounds] which results in increased expression of GSTP1 mRNA	16814760
D000165	Acridine Orange	[Acridine Orange binds to Platinum] which results in increased expression of GSTP1 mRNA	16814760
D000171	Acrolein	Acrolein binds to and results in decreased activity of GSTP1 protein	9463521
D000171	Acrolein	GSTP1 protein polymorphism results in increased metabolism of Acrolein	10799737
D000171	Acrolein	GSTP1 protein results in increased metabolism of Acrolein	10799737
D000171	Acrolein	Acrolein results in increased expression of GSTP1 mRNA	18515264
D000171	Acrolein	Acrolein results in increased expression of GSTP1 protein	28482051
D000171	Acrolein	GSTP1 protein results in increased metabolism of Acrolein	19696094
D000171	Acrolein	Acrolein results in increased expression of GSTP1 protein	11600134; 16242832;
D020106	Acrylamide	Acrylamide results in increased expression of GSTP1 mRNA	17961207
D020106	Acrylamide	Acrylamide results in increased expression of GSTP1 protein modified form	29784925
D020106	Acrylamide	Acrylamide results in increased expression of GSTP1 mRNA	15749267; 28959563;
C038518	acrylodan	GSTP1 protein affects the metabolism of [acrylodan co-treated with Glutathione]	12470677
D000255	Adenosine Triphosphate	[GSTP1 protein co-treated with Glutathione] inhibits the reaction [Adenosine Triphosphate results in increased activity of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine]	11196146
D000255	Adenosine Triphosphate	[GSTP1 protein co-treated with Glutathione] inhibits the reaction [[Adenosine Triphosphate results in increased metabolism of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased abundance of 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct]	11196146
D016604	Aflatoxin B1	Aflatoxin B1 results in increased methylation of GSTP1 promoter	15808399
D016604	Aflatoxin B1	Aflatoxin B1 results in decreased expression of and results in decreased activity of GSTP1 protein	25154877
D016604	Aflatoxin B1	Aflatoxin B1 results in increased expression of GSTP1 mRNA	23052194; 23630614; 25378103;
D016604	Aflatoxin B1	Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of and results in decreased activity of GSTP1 protein]	25154877
C006426	aflatoxin B1-2,3-oxide	GSTP1 protein affects the metabolism of aflatoxin B1-2,3-oxide	1638515
D000393	Air Pollutants	GSTP1 gene polymorphism affects the susceptibility to Air Pollutants	20194081; 22732554;
D000395	Air Pollutants, Occupational	GSTP1 gene polymorphism affects the susceptibility to Air Pollutants, Occupational	20480816
D000450	Aldosterone	Aldosterone results in increased expression of GSTP1 protein	25204689
D000077556	Alitretinoin	Alitretinoin results in decreased expression of GSTP1 mRNA	30248606
D000477	Alkylating Agents	GSTP1 mRNA results in increased susceptibility to Alkylating Agents	8700107
D000477	Alkylating Agents	GSTP1 protein results in increased susceptibility to Alkylating Agents	8700107
D000498	Allyl Compounds	Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein]	15554553
C004471	allyl isothiocyanate	GSTP1 protein affects the metabolism of allyl isothiocyanate	7826396
C038491	allyl sulfide	allyl sulfide results in increased expression of GSTP1 mRNA	17937621
C038491	allyl sulfide	allyl sulfide inhibits the reaction [Diethylnitrosamine results in increased expression of and results in increased activity of GSTP1 protein]	23494807
C038491	allyl sulfide	allyl sulfide inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 mRNA]	23494807
C038491	allyl sulfide	allyl sulfide results in increased expression of GSTP1 mRNA	19695238
D000517	alpha-Chlorohydrin	alpha-Chlorohydrin results in increased expression of GSTP1 mRNA	28522335
C040534	alpha-hexachlorocyclohexane	alpha-hexachlorocyclohexane results in increased expression of GSTP1 mRNA	16940010
C040534	alpha-hexachlorocyclohexane	[Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in decreased expression of GSTP1 protein	16246485
C040534	alpha-hexachlorocyclohexane	[Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of GSTP1 protein	16246485
C011512	alpha-naphthoflavone	[beta-Naphthoflavone co-treated with alpha-naphthoflavone] results in increased expression of GSTP1 mRNA	19233942
C011512	alpha-naphthoflavone	alpha-naphthoflavone results in decreased expression of GSTP1 mRNA	18762178
D000577	Amides	Amides results in increased expression of GSTP1 mRNA	23063670
D000577	Amides	Amides results in increased expression of GSTP1 protein	23063670
D000638	Amiodarone	Amiodarone affects the expression of GSTP1 mRNA	25064622
D000639	Amitriptyline	Amitriptyline results in decreased activity of GSTP1 protein	15094841
D000643	Ammonium Chloride	Ammonium Chloride affects the expression of GSTP1 mRNA	16483693
C094705	amodiaquine quinoneimine	[GSTP1 protein co-treated with Glutathione] results in increased metabolism of amodiaquine quinoneimine	28478157
D000666	Amphotericin B	Amphotericin B inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D000666	Amphotericin B	Amphotericin B results in decreased expression of GSTP1 mRNA	20623750
C019257	angelica lactone	angelica lactone results in increased expression of GSTP1 protein	11309284
D000875	Anthralin	Anthralin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C526219	apple polyphenol extract	apple polyphenol extract results in increased expression of GSTP1 mRNA	16369997
C030610	argemone oil	argemone oil results in increased expression of GSTP1 protein	15981203
C000228	aristolochic acid I	[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of GSTP1 mRNA	23912714
C000228	aristolochic acid I	aristolochic acid I results in increased expression of GSTP1 mRNA	17483316
C042310	aristolochic acid II	[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of GSTP1 mRNA	23912714
D001151	Arsenic	Arsenic results in increased expression of GSTP1 mRNA	29247444
D001151	Arsenic	GSTP1 gene affects the susceptibility to Arsenic	17284320
D001151	Arsenic	GSTP1 gene SNP affects the susceptibility to Arsenic	22306368
D000077237	Arsenic Trioxide	Arsenic Trioxide results in increased expression of GSTP1 mRNA	17961207
D000077237	Arsenic Trioxide	Arsenic Trioxide promotes the reaction [Decitabine results in increased expression of GSTP1 mRNA]	16613325
D000077237	Arsenic Trioxide	Arsenic Trioxide results in decreased methylation of GSTP1 promoter	16613325
D000077237	Arsenic Trioxide	[Arsenic Trioxide results in decreased methylation of GSTP1 promoter] which results in increased expression of GSTP1 mRNA	16613325; 16613325;
D000077237	Arsenic Trioxide	Arsenic Trioxide results in increased expression of and affects the localization of GSTP1 protein	16613325
D000077237	Arsenic Trioxide	Arsenic Trioxide results in increased expression of GSTP1 mRNA	16613325
D000077237	Arsenic Trioxide	Decitabine promotes the reaction [Arsenic Trioxide results in increased expression of GSTP1 mRNA]	16613325
D000077237	Arsenic Trioxide	GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP3 protein]	23082001
D000077237	Arsenic Trioxide	GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein]	23082001
D000077237	Arsenic Trioxide	GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]	23082001
D000077237	Arsenic Trioxide	GSTP1 protein results in decreased susceptibility to Arsenic Trioxide	15231573
D000077237	Arsenic Trioxide	GSTP1 protein results in decreased susceptibility to [Arsenic Trioxide co-treated with Ethacrynic Acid]	23082001
D000077237	Arsenic Trioxide	GSTP1 protein results in decreased abundance of Arsenic Trioxide	15231573
C015001	arsenite	GSTP1 protein results in increased transport of arsenite	15161912
C015001	arsenite	[arsenite co-treated with Benzo(a)pyrene] results in increased expression of GSTP1 mRNA	15894712
C015001	arsenite	arsenite results in increased expression of GSTP1 mRNA	15345372; 15894712;
C031327	artemisinine	artemisinine results in decreased activity of GSTP1 protein	11807801
D000077332	Artesunate	Artesunate results in decreased expression of GSTP1 protein	19513562
D001194	Asbestos	GSTP1 gene polymorphism affects the susceptibility to Asbestos	17159790
D017638	Asbestos, Crocidolite	Asbestos, Crocidolite results in increased expression of GSTP1 mRNA	29523930
D053626	Atovaquone	Atovaquone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D001280	Atrazine	GSTP1 protein affects the metabolism of [Atrazine co-treated with Glutathione]	15115887
D001280	Atrazine	GSTP1 protein promotes the reaction [Glutathione binds to Atrazine]	18607078
D001280	Atrazine	GSTP1 protein results in increased metabolism of Atrazine	7873571
D001280	Atrazine	Atrazine results in increased expression of GSTP1 mRNA	23070809
D001280	Atrazine	Quercetin inhibits the reaction [Atrazine results in increased expression of GSTP1 mRNA]	23070809
D006051	Aurothioglucose	Aurothioglucose inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C049935	avobenzone	avobenzone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D001507	Beclomethasone	Beclomethasone results in increased expression of GSTP1 mRNA	23656298
C030935	benz(a)anthracene	[benz(a)anthracene co-treated with benzo(k)fluoranthene co-treated with benzo(b)fluoranthene co-treated with chrysene co-treated with Benzo(a)pyrene] results in increased expression of GSTP1 mRNA	27283969
D001554	Benzene	Benzene results in increased expression of GSTP1 mRNA	18952161
D001554	Benzene	GSTP1 gene polymorphism affects the susceptibility to Benzene	15591089
D001554	Benzene	GSTP1 protein affects the metabolism of Benzene	15226677
D001554	Benzene	GSTP1 protein results in increased metabolism of Benzene	17885617
D001554	Benzene	Benzene results in decreased expression of GSTP1 protein	8347175
C023372	benzene oxide	GSTP1 protein results in increased metabolism of benzene oxide	26554337
D001564	Benzo(a)pyrene	[benz(a)anthracene co-treated with benzo(k)fluoranthene co-treated with benzo(b)fluoranthene co-treated with chrysene co-treated with Benzo(a)pyrene] results in increased expression of GSTP1 mRNA	27283969
D001564	Benzo(a)pyrene	[Benzo(a)pyrene co-treated with fluoranthene] affects the expression of GSTP1 mRNA	25412620
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of GSTP1 mRNA	22209252; 26001963;
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of GSTP1 mRNA	18952161; 20498004; 22316170;
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of GSTP1 protein	20498004
D001564	Benzo(a)pyrene	Buthionine Sulfoximine inhibits the reaction [GSTP1 results in decreased susceptibility to Benzo(a)pyrene]	19330882
D001564	Benzo(a)pyrene	GSTP1 protein polymorphism affects the metabolism of and affects the activity of Benzo(a)pyrene	15298956
D001564	Benzo(a)pyrene	GSTP1 protein results in decreased susceptibility to Benzo(a)pyrene	2747627
D001564	Benzo(a)pyrene	GSTP1 protein results in decreased susceptibility to Benzo(a)pyrene metabolite	2747627
D001564	Benzo(a)pyrene	GSTP1 results in decreased susceptibility to Benzo(a)pyrene	19330882
D001564	Benzo(a)pyrene	AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of GSTP1 mRNA]	15034205
D001564	Benzo(a)pyrene	[arsenite co-treated with Benzo(a)pyrene] results in increased expression of GSTP1 mRNA	15894712
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of and results in increased activity of GSTP1 protein	30938511
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of GSTP1 mRNA	14625279; 15034205; 15894712; 21569818; 22228805;
D001564	Benzo(a)pyrene	[chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of GSTP1 mRNA	25820237
D001564	Benzo(a)pyrene	[lipopolysaccharide, E coli O55-B5 co-treated with Benzo(a)pyrene] affects the expression of GSTP1 mRNA	28987381
D001564	Benzo(a)pyrene	[Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of GSTP1 mRNA]	14625279
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of GSTP1 mRNA	28651000
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of GSTP1 protein	9395218
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of GSTP1 mRNA	20382262
C006703	benzo(b)fluoranthene	[benz(a)anthracene co-treated with benzo(k)fluoranthene co-treated with benzo(b)fluoranthene co-treated with chrysene co-treated with Benzo(a)pyrene] results in increased expression of GSTP1 mRNA	27283969
C041512	benzo(b)fluorene	[Benzophenanthridines analog co-treated with benzo(b)fluorene co-treated with retene] results in increased expression of GSTP1 mRNA	22120849
C110144	benzo(c)chrysene	GSTP1 protein affects the metabolism of [benzo(c)chrysene co-treated with Glutathione]	9403173
C002615	benzo(c)phenanthrene	GSTP1 gene polymorphism affects the metabolism of benzo(c)phenanthrene analog	9850062
C002615	benzo(c)phenanthrene	GSTP1 protein affects the metabolism of [benzo(c)phenanthrene co-treated with Glutathione]	9403173
C100422	benzo(g)chrysene	GSTP1 gene polymorphism affects the metabolism of benzo(g)chrysene analog	9850062
C100422	benzo(g)chrysene	GSTP1 protein affects the metabolism of [benzo(g)chrysene co-treated with Glutathione]	9403173
C089231	benzo(g)chrysene-11,12-dihydrodiol-13,14-epoxide	GSTP1 protein results in increased glutathionylation of benzo(g)chrysene-11,12-dihydrodiol-13,14-epoxide	9308905
C022921	benzo(k)fluoranthene	[benz(a)anthracene co-treated with benzo(k)fluoranthene co-treated with benzo(b)fluoranthene co-treated with chrysene co-treated with Benzo(a)pyrene] results in increased expression of GSTP1 mRNA	27283969
C022921	benzo(k)fluoranthene	benzo(k)fluoranthene results in increased expression of GSTP1 mRNA	27283969
C022921	benzo(k)fluoranthene	benzo(k)fluoranthene affects the expression of GSTP1 mRNA	26377693
D053119	Benzophenanthridines	[Benzophenanthridines analog co-treated with benzo(b)fluorene co-treated with retene] results in increased expression of GSTP1 mRNA	22120849
D001578	Benzopyrans	Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of and results in decreased activity of GSTP1 protein]	25154877
D001578	Benzopyrans	Benzopyrans results in increased expression of and results in increased activity of GSTP1 protein	25154877
D001580	Benzopyrenes	GSTP1 protein affects the metabolism of Benzopyrenes analog	3592675
C031403	benzyl isothiocyanate	benzyl isothiocyanate binds to and results in decreased activity of GSTP1 protein	15355982
C031403	benzyl isothiocyanate	benzyl isothiocyanate results in decreased activity of GSTP1 protein	17937621
C031403	benzyl isothiocyanate	benzyl isothiocyanate results in increased expression of GSTP1 protein	29667773
C031403	benzyl isothiocyanate	GSTP1 protein affects the metabolism of benzyl isothiocyanate	15355982; 7826396;
C031403	benzyl isothiocyanate	benzyl isothiocyanate results in increased expression of GSTP1 protein	9794803
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GSTP1 protein	15863507
C038328	BEP protocol	BEP protocol results in increased expression of GSTP1 mRNA	18987330; 23200778;
C038328	BEP protocol	BEP protocol results in increased expression of GSTP1 protein	23200778
C014638	beta-lapachone	beta-lapachone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA]	15313406
C014638	beta-lapachone	beta-lapachone inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA]	15313406
C011175	betamethasone-17,21-dipropionate	betamethasone-17,21-dipropionate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D019324	beta-Naphthoflavone	[beta-Naphthoflavone co-treated with alpha-naphthoflavone] results in increased expression of GSTP1 mRNA	19233942
D019324	beta-Naphthoflavone	beta-Naphthoflavone results in increased expression of GSTP1 protein	23063670
D019324	beta-Naphthoflavone	beta-Naphthoflavone results in increased expression of GSTP1 mRNA	19118567; 19695238;
D019324	beta-Naphthoflavone	beta-Naphthoflavone results in increased expression of GSTP1 protein	9794803
C477843	bicyclol	bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 mRNA]	17106253
C477843	bicyclol	bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	17106253
C099952	bifenthrin	bifenthrin results in increased expression of GSTP1 mRNA	26071804
D001663	Bilirubin	Bilirubin results in decreased expression of GSTP1 mRNA	20196124
C070515	bisindolylmaleimide I	bisindolylmaleimide I inhibits the reaction [Cadmium Chloride results in increased expression of GSTP1 mRNA]	24316436
C006780	bisphenol A	bisphenol A results in increased expression of GSTP1 mRNA	29458080; 30248606;
C006780	bisphenol A	bisphenol A affects the expression of GSTP1 mRNA	25181051; 30903817;
C006780	bisphenol A	bisphenol A results in decreased expression of GSTP1 mRNA	30816183
C006780	bisphenol A	bisphenol A results in decreased expression of GSTP1 protein	27208089
C006780	bisphenol A	bisphenol A results in increased methylation of GSTP1 gene	28505145
C512161	bisphenol A glucuronide	GSTP1 gene polymorphism affects the abundance of bisphenol A glucuronide	29411558
C010689	bromindione	bromindione inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C032036	bromobenzene	bromobenzene results in increased expression of GSTP1 protein	10547960
C026535	bucillamine	bucillamine inhibits the reaction [chlorobenzene results in increased expression of GSTP1 protein]	19800902
C022777	bufalin	bufalin results in decreased expression of GSTP1 protein	23091618
D002065	Buspirone	Buspirone results in increased expression of GSTP1 mRNA	24136188
D002066	Busulfan	GSTP1 gene polymorphism affects the abundance of Busulfan	20672371
D002066	Busulfan	GSTP1 protein affects the metabolism of Busulfan	8886613
D019328	Buthionine Sulfoximine	Buthionine Sulfoximine inhibits the reaction [GSTP1 results in decreased susceptibility to Benzo(a)pyrene]	19330882
D019328	Buthionine Sulfoximine	Buthionine Sulfoximine inhibits the reaction [Microcystins analog results in increased expression of GSTP1 mRNA]	24964298
D002083	Butylated Hydroxyanisole	Butylated Hydroxyanisole results in increased activity of GSTP1 protein	11895860
D002083	Butylated Hydroxyanisole	Butylated Hydroxyanisole results in increased expression of GSTP1 protein	11895860; 2597111;
D002083	Butylated Hydroxyanisole	NFE2L2 protein affects the reaction [Butylated Hydroxyanisole results in increased activity of GSTP1 protein]	11895860
D002083	Butylated Hydroxyanisole	NFE2L2 protein affects the reaction [Butylated Hydroxyanisole results in increased expression of GSTP1 protein]	11895860
D002083	Butylated Hydroxyanisole	Butylated Hydroxyanisole results in increased expression of GSTP1 protein	9794803
D002084	Butylated Hydroxytoluene	Butylated Hydroxytoluene results in increased alkylation of and results in decreased activity of GSTP1 protein	21536018
D002084	Butylated Hydroxytoluene	Butylated Hydroxytoluene results in increased expression of GSTP1 mRNA	15110098
D002087	Butyrates	Butyrates results in increased expression of GSTP1 mRNA	15746163
D002087	Butyrates	Butyrates results in increased expression of GSTP1 protein	12896903
D020148	Butyric Acid	Butyric Acid results in decreased expression of GSTP1 mRNA	30439556
D002101	Cacodylic Acid	Cacodylic Acid results in increased expression of GSTP1 mRNA	16122865; 17481689;
D002104	Cadmium	Cadmium affects the expression of GSTP1 mRNA	20549629
D002104	Cadmium	[Copper co-treated with Cadmium] affects the expression of GSTP1 mRNA	20549629
D002104	Cadmium	Cadmium results in increased expression of GSTP1 mRNA	28212397
D002104	Cadmium	Cadmium results in increased expression of GSTP1 mRNA	22562489
D002104	Cadmium	GSTP1 protein inhibits the reaction [Cadmium results in increased activity of CASP3 protein]	21787653
D002104	Cadmium	GSTP1 protein inhibits the reaction [Cadmium results in increased phosphorylation of MAPK1 protein]	21787653
D002104	Cadmium	GSTP1 protein inhibits the reaction [Cadmium results in increased phosphorylation of MAPK3 protein]	21787653
D019256	Cadmium Chloride	Cadmium Chloride results in decreased expression of GSTP1 mRNA	22941245
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of GSTP1 protein	24527689
D019256	Cadmium Chloride	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of GSTP1 mRNA	19840844
D019256	Cadmium Chloride	bisindolylmaleimide I inhibits the reaction [Cadmium Chloride results in increased expression of GSTP1 mRNA]	24316436
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of GSTP1 mRNA	24316436
D019256	Cadmium Chloride	cariporide inhibits the reaction [Cadmium Chloride results in increased expression of GSTP1 mRNA]	24316436
D019256	Cadmium Chloride	Wortmannin inhibits the reaction [Cadmium Chloride results in increased expression of GSTP1 mRNA]	24316436
D019256	Cadmium Chloride	[Cadmium Chloride co-treated with zinc chloride] results in increased expression of GSTP1 protein	15602745
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of GSTP1	17483498
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of GSTP1 protein	21699967
C053400	cafestol	[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTP1 protein]	17110534
C040048	caffeic acid	caffeic acid results in decreased activity of GSTP1 protein	8340025
C055494	caffeic acid phenethyl ester	caffeic acid phenethyl ester results in decreased expression of GSTP1 protein	17106925
D002110	Caffeine	Caffeine results in decreased expression of GSTP1 mRNA	22982570
D002166	Camptothecin	Camptothecin results in increased expression of GSTP1 protein	15500952
D002166	Camptothecin	GSTP1 protein polymorphism results in decreased susceptibility to Camptothecin	15500952
D002166	Camptothecin	GSTP1 protein results in decreased susceptibility to Camptothecin	14732228; 15500952;
D002211	Capsaicin	Capsaicin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA]	15313406
D002211	Capsaicin	Capsaicin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA]	15313406
C001614	captafol	captafol results in decreased activity of GSTP1 protein	8678907
C001614	captafol	hexylglutathione inhibits the reaction [captafol results in decreased activity of GSTP1 protein]	8678907
D002215	Captan	Captan results in decreased activity of GSTP1 protein	8678907
D002215	Captan	hexylglutathione inhibits the reaction [Captan results in decreased activity of GSTP1 protein]	8678907
D002220	Carbamazepine	Carbamazepine results in increased expression of GSTP1 mRNA	22982570
C012227	carbamazepine epoxide	carbamazepine epoxide binds to GSTP1 protein	28562019
D002251	Carbon Tetrachloride	Carbon Tetrachloride affects the expression of GSTP1 mRNA	17484886
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased expression of GSTP1 mRNA	15963578
D002251	Carbon Tetrachloride	Carbon Tetrachloride affects the expression of GSTP1 mRNA	12734012
D002251	Carbon Tetrachloride	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTP1 protein	12725062
D002251	Carbon Tetrachloride	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein	12725062
D002251	Carbon Tetrachloride	Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTP1 protein]	12725062
D002251	Carbon Tetrachloride	Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein]	12725062
D016190	Carboplatin	GSTP1 gene affects the susceptibility to Carboplatin	12360105
C093373	cariporide	cariporide inhibits the reaction [Cadmium Chloride results in increased expression of GSTP1 mRNA]	24316436
D002330	Carmustine	GSTP1 gene SNP results in increased susceptibility to [Carmustine co-treated with Doxorubicin co-treated with Cyclophosphamide co-treated with Melphalan]	12791655
D002330	Carmustine	GSTP1 protein results in decreased susceptibility to Carmustine	16899598
C006923	carvone	carvone results in increased expression of GSTP1 mRNA	27750016
D000068579	Celecoxib	Celecoxib results in increased expression of GSTP1 mRNA	18089846
D000068579	Celecoxib	PTGS2 protein affects the reaction [Celecoxib results in increased expression of GSTP1 mRNA]	18089846
D002509	Cephaloridine	Cephaloridine results in increased expression of GSTP1 mRNA	18500788
C026690	cerous chloride	cerous chloride results in decreased expression of GSTP1 mRNA	28954213
D002699	Chlorambucil	Chlorambucil binds to GSTP1 protein	18511072
D002699	Chlorambucil	GSTP1 gene affects the susceptibility to Chlorambucil	11071881
D002699	Chlorambucil	GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Chlorambucil]	10900222
D002699	Chlorambucil	GSTP1 protein results in decreased susceptibility to Chlorambucil	10900222
D002699	Chlorambucil	GSTP1 protein results in increased metabolism of Chlorambucil	11071881
C030578	chloramphenicol palmitate	chloramphenicol palmitate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C031294	chlorobenzene	bucillamine inhibits the reaction [chlorobenzene results in increased expression of GSTP1 protein]	19800902
C031294	chlorobenzene	chlorobenzene results in increased expression of GSTP1 mRNA	19800902
C031294	chlorobenzene	chlorobenzene results in increased expression of GSTP1 protein	19800902
C031294	chlorobenzene	Tiopronin inhibits the reaction [chlorobenzene results in increased expression of GSTP1 protein]	19800902
D020111	Chlorodiphenyl (54% Chlorine)	Chlorodiphenyl (54% Chlorine) results in increased expression of GSTP1 mRNA	16945589
D002735	Chlorophyllides	Chlorophyllides inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D002735	Chlorophyllides	Ethacrynic Acid inhibits the reaction [Chlorophyllides inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]]	23769903
C100187	chloropicrin	chloropicrin results in decreased expression of GSTP1 mRNA	26352163
D002741	Chlorotrianisene	Chlorotrianisene inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D002746	Chlorpromazine	Chlorpromazine affects the expression of GSTP1 mRNA	25064622
D002751	Chlortetracycline	Chlortetracycline inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C074702	chromium hexavalent ion	[chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of GSTP1 mRNA	25820237
C074702	chromium hexavalent ion	chromium hexavalent ion affects the expression of GSTP1 mRNA	22673405
C031180	chrysene	[benz(a)anthracene co-treated with benzo(k)fluoranthene co-treated with benzo(b)fluoranthene co-treated with chrysene co-treated with Benzo(a)pyrene] results in increased expression of GSTP1 mRNA	27283969
C021977	chrysene,2-diol-3,4-epoxide-1	GSTP1 protein results in increased glutathionylation of chrysene,2-diol-3,4-epoxide-1	9281308
C021977	chrysene,2-diol-3,4-epoxide-1	GSTP1 protein results in increased glutathionylation of chrysene,2-diol-3,4-epoxide-1	9308905
D002927	Cimetidine	Cimetidine affects the expression of GSTP1 protein	22733800
D002927	Cimetidine	[Monocrotophos co-treated with Cimetidine] results in increased expression of GSTP1 protein	22733800
C012843	cinnamic aldehyde	cinnamic aldehyde binds to and results in decreased activity of GSTP1 protein	9463521
C530333	cis-diammine(pyridine)chloroplatinum(II)	GSTP1 affects the susceptibility to cis-diammine(pyridine)chloroplatinum(II)	21750216
D002945	Cisplatin	[Cisplatin co-treated with Fluorouracil] results in decreased expression of GSTP1 mRNA	15737843
D002945	Cisplatin	Cisplatin results in increased expression of GSTP1 mRNA	27392435
D002945	Cisplatin	GSTP1 gene affects the susceptibility to Cisplatin	12360105
D002945	Cisplatin	GSTP1 gene polymorphism affects the susceptibility to Cisplatin	16785472
D002945	Cisplatin	GSTP1 gene polymorphism results in decreased susceptibility to [Fluorouracil co-treated with Cisplatin]	16622263
D002945	Cisplatin	GSTP1 mRNA affects the susceptibility to Cisplatin	8055443
D002945	Cisplatin	GSTP1 mRNA results in increased susceptibility to Cisplatin	15239142
D002945	Cisplatin	GSTP1 protein results in decreased susceptibility to Cisplatin	15279901; 19396019;
D002945	Cisplatin	GSTP1 results in decreased susceptibility to Cisplatin	14678959
D002945	Cisplatin	[PRKCA protein results in increased phosphorylation of GSTP1 protein] which results in increased metabolism of Cisplatin	20654585
D002945	Cisplatin	[[PRKCA protein results in increased phosphorylation of GSTP1 protein] which results in increased metabolism of Cisplatin] which results in decreased susceptibility to Cisplatin	20654585
D002945	Cisplatin	GSTP1 protein results in decreased susceptibility to Cisplatin	12964789
D002945	Cisplatin	GSTP1 protein results in decreased susceptibility to Cisplatin	11455017
C098869	clasto-lactacystin beta-lactone	clasto-lactacystin beta-lactone results in increased expression of GSTP1 protein	15863507
D002990	Clobetasol	Clobetasol results in increased expression of GSTP1 mRNA	27462272
D002991	Clofazimine	Clofazimine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D002994	Clofibrate	[Clofibrate co-treated with Acetaminophen] affects the expression of GSTP1 mRNA	17585979
D002994	Clofibrate	Clofibrate results in decreased expression of GSTP1 mRNA	17585979
D002994	Clofibrate	PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GSTP1 mRNA]	17585979
D002994	Clofibrate	[Clofibrate co-treated with PPARA protein] inhibits the reaction [JUN protein results in increased expression of GSTP1 mRNA]	7585603
D002994	Clofibrate	[Clofibrate co-treated with PPARA protein] results in decreased expression of GSTP1 mRNA	7585603
D002994	Clofibrate	Clofibrate results in decreased expression of GSTP1 mRNA	7585603
D002995	Clofibric Acid	Clofibric Acid results in increased expression of GSTP1 mRNA	22559005
D002997	Clomipramine	Clomipramine results in decreased activity of GSTP1 protein	15094841
D003022	Clotrimazole	Clotrimazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D003024	Clozapine	Clozapine metabolite binds to GSTP1 protein	21639118
D003024	Clozapine	Clozapine metabolite results in decreased activity of GSTP1 protein	21639118
D003024	Clozapine	GSTP1 protein affects the metabolism of Clozapine metabolite	24185126
D003024	Clozapine	GSTP1 protein results in decreased activity of Clozapine	20849150
D003024	Clozapine	GSTP1 protein results in increased glutathionylation of Clozapine	20849150
D003033	Coal Tar	Coal Tar results in increased expression of GSTP1 mRNA	16882163
D003033	Coal Tar	[Vehicle Emissions analog co-treated with Coal Tar analog co-treated with Tobacco Smoke Pollution analog] results in increased expression of GSTP1 mRNA	22935520
D003033	Coal Tar	[Vehicle Emissions analog co-treated with Coal Tar analog] results in increased expression of GSTP1 mRNA	22935520
C018021	cobaltous chloride	cobaltous chloride results in increased expression of GSTP1 mRNA	24612858
C000913	cobamamide	cobamamide inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D003042	Cocaine	GSTP1 polymorphism affects the susceptibility to Cocaine	16272961
D003300	Copper	Copper affects the expression of GSTP1 mRNA	20549629
D003300	Copper	[Copper co-treated with Cadmium] affects the expression of GSTP1 mRNA	20549629
D003300	Copper	Copper results in increased expression of GSTP1 mRNA	25119852
D003300	Copper	Copper results in increased expression of GSTP1 protein	24211336
C515714	copper (N-2-hydroxyacetophenone)glycinate	copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of GSTP1 protein	16289015
C515714	copper (N-2-hydroxyacetophenone)glycinate	[copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of GSTP1 protein] which results in increased susceptibility to Doxorubicin	16289015
C030123	coumarin	coumarin results in increased expression of GSTP1 protein	11309284
C030123	coumarin	coumarin results in increased expression of GSTP1 protein	9794803
C015763	cumene	cumene affects the localization of GSTP1 protein	18409811
C015763	cumene	cumene results in decreased activity of GSTP1 protein	18409811
C007164	cumene hydroperoxide	GSTP1 protein results in increased metabolism of cumene hydroperoxide	2747627
C007164	cumene hydroperoxide	GSTP1 protein affects the metabolism of cumene hydroperoxide	11684093
D003474	Curcumin	Curcumin affects the expression of GSTP1 protein	22830632
D003474	Curcumin	Curcumin binds to and results in decreased activity of GSTP1 protein	9463521
D003474	Curcumin	Curcumin inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide]	15999103
D003474	Curcumin	Curcumin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA]	14555224
D003474	Curcumin	Curcumin promotes the reaction [NFE2L2 protein binds to GSTP1 promoter]	17449203
D003474	Curcumin	Curcumin promotes the reaction [NFE2L2 protein results in increased expression of GSTP1 mRNA]	17449203
D003474	Curcumin	Curcumin results in decreased expression of GSTP1 mRNA	14555224; 18414057;
D003474	Curcumin	Curcumin results in decreased expression of GSTP1 protein	14555224
D003474	Curcumin	Curcumin results in increased expression of GSTP1 mRNA	16101141; 17449203;
D003474	Curcumin	Curcumin results in increased expression of GSTP1 protein	14742295
D003474	Curcumin	[sulfinosine co-treated with Curcumin] results in decreased expression of GSTP1 mRNA	18414057
D003474	Curcumin	Curcumin results in increased expression of GSTP1 mRNA	18299980
C057862	cyanoginosin LR	GSTP1 protein results in increased glutathionylation of and affects the susceptibility to cyanoginosin LR	21504230
D003511	Cyclohexanols	[Diethylnitrosamine co-treated with Cyclohexanols] results in increased expression of GSTP1 protein	17393424
D003520	Cyclophosphamide	GSTP1 gene SNP results in increased susceptibility to [Carmustine co-treated with Doxorubicin co-treated with Cyclophosphamide co-treated with Melphalan]	12791655
D003520	Cyclophosphamide	GSTP1 protein affects the reaction [Cyclophosphamide results in increased phosphorylation of MAPK8 protein]	19696094
D003520	Cyclophosphamide	GSTP1 protein affects the susceptibility to Cyclophosphamide	19696094
D003520	Cyclophosphamide	GSTP1 protein results in decreased susceptibility to Cyclophosphamide	10954901
D003520	Cyclophosphamide	Mesna inhibits the reaction [GSTP1 protein affects the reaction [Cyclophosphamide results in increased phosphorylation of MAPK8 protein]]	19696094
D003520	Cyclophosphamide	Cyclophosphamide results in increased expression of GSTP1 mRNA	16141653; 16242832;
D003520	Cyclophosphamide	Cyclophosphamide results in increased expression of GSTP1 protein	16242832
D016572	Cyclosporine	Cyclosporine affects the expression of GSTP1 mRNA	25064622
C017160	cypermethrin	cypermethrin results in decreased expression of GSTP1 mRNA	22528246
D003545	Cysteine	Cysteine affects the expression of GSTP1 protein	15203113
D003609	Dactinomycin	GSTP1 protein results in decreased susceptibility to Dactinomycin	11455017
D003622	Dapsone	Dapsone inhibits the reaction [Paraquat results in decreased expression of GSTP1 protein]	21765237
C017180	decamethrin	decamethrin results in increased expression of GSTP1 mRNA	22889898; 23076637;
D000077209	Decitabine	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Decitabine results in increased expression of GSTP1 protein]	19396019
D000077209	Decitabine	Arsenic Trioxide promotes the reaction [Decitabine results in increased expression of GSTP1 mRNA]	16613325
D000077209	Decitabine	[Decitabine co-treated with trichostatin A] results in increased expression of GSTP1 mRNA	17891453
D000077209	Decitabine	Decitabine promotes the reaction [Arsenic Trioxide results in increased expression of GSTP1 mRNA]	16613325
D000077209	Decitabine	Decitabine results in decreased methylation of GSTP1 gene	19840838
D000077209	Decitabine	Decitabine results in decreased methylation of GSTP1 promoter	16613325; 18174752; 18676679;
D000077209	Decitabine	[Decitabine results in decreased methylation of GSTP1 promoter] which results in increased expression of GSTP1 mRNA	16613325; 16613325;
D000077209	Decitabine	Decitabine results in increased expression of GSTP1 mRNA	16613325; 18174752; 18676679; 19840838;
D000077209	Decitabine	Decitabine results in increased expression of GSTP1 protein	16613325; 18676679; 19396019;
D000077209	Decitabine	[Decitabine co-treated with trichostatin A] results in increased expression of GSTP1 mRNA	19444856
D003671	DEET	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GSTP1 mRNA	28659758
D003840	Deoxycholic Acid	Deoxycholic Acid binds to GSTP1 protein	15300575
D003840	Deoxycholic Acid	gamma-Glu-S-BzCys-PhGly diethyl ester inhibits the reaction [GSTP1 protein results in increased susceptibility to Deoxycholic Acid]	15300575
D003840	Deoxycholic Acid	GSTP1 protein results in increased susceptibility to Deoxycholic Acid	15300575
C047386	desethylamodiaquine	[GSTP1 protein co-treated with Glutathione] results in increased metabolism of desethylamodiaquine	28478157
D003907	Dexamethasone	Acetylcarnitine affects the reaction [Dexamethasone results in decreased expression of GSTP1 mRNA]	21986892
D003907	Dexamethasone	Dexamethasone results in decreased expression of GSTP1 mRNA	20832446; 21986892; 7585603;
D003907	Dexamethasone	Melatonin affects the reaction [Dexamethasone results in decreased expression of GSTP1 mRNA]	21986892
C042577	diallyl trisulfide	diallyl trisulfide results in decreased expression of GSTP1 mRNA	16344271
C042577	diallyl trisulfide	diallyl trisulfide results in decreased expression of GSTP1 protein	16344271
C042577	diallyl trisulfide	diallyl trisulfide promotes the reaction [JUN protein binds to GSTP1 enhancer]	20237067
C042577	diallyl trisulfide	[diallyl trisulfide promotes the reaction [JUN protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA	20237067; 20237067;
C042577	diallyl trisulfide	diallyl trisulfide promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]	20237067
C042577	diallyl trisulfide	[diallyl trisulfide promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA	20237067; 20237067;
C042577	diallyl trisulfide	diallyl trisulfide results in increased expression of and results in increased activity of GSTP1 protein	20237067
C042577	diallyl trisulfide	diallyl trisulfide results in increased expression of GSTP1 mRNA	20237067
C041517	dibenzo(a,l)pyrene	GSTP1 protein affects the metabolism of and results in decreased activity of [dibenzo(a,l)pyrene co-treated with Glutathione]	11849043
C041517	dibenzo(a,l)pyrene	GSTP1 results in decreased susceptibility to dibenzo(a,l)pyrene	19330882
D003993	Dibutyl Phthalate	Dibutyl Phthalate results in increased expression of GSTP1 mRNA	17379624; 21266533;
D004008	Diclofenac	[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac	24246759
D004008	Diclofenac	[[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac	24246759
D004008	Diclofenac	[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased metabolism of Diclofenac	24246759
D004008	Diclofenac	[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac	24246759
D004008	Diclofenac	[[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac	24246759
D004008	Diclofenac	[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of Diclofenac	24246759
D004008	Diclofenac	[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac	24246759
D004008	Diclofenac	[[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 5-hydroxydiclofenac	24246759
D004008	Diclofenac	Diclofenac affects the activity of GSTP1 protein	27183920
D004008	Diclofenac	GSTP1 protein affects the metabolism of Diclofenac metabolite	24185126
D004008	Diclofenac	GSTP1 protein polymorphism affects the metabolism of Diclofenac metabolite	24185126
C036042	dicyclohexyl phthalate	dicyclohexyl phthalate results in increased expression of GSTP1 mRNA	26924002
D004028	Dienestrol	Dienestrol inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D004041	Dietary Fats	[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of GSTP1 mRNA	28433925
D004041	Dietary Fats	Dietary Fats results in decreased expression of GSTP1 mRNA	30120929
D004041	Dietary Fats	[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dietary Fats] results in decreased expression of GSTP1 mRNA	12097258
D019422	Dietary Sucrose	[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of GSTP1 mRNA	28433925
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in decreased expression of GSTP1 mRNA	19245819
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in increased expression of GSTP1 mRNA	29689378
C014476	diethyl maleate	diethyl maleate results in increased expression of GSTP1 protein	9794803
D004052	Diethylnitrosamine	[2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein	18271918
D004052	Diethylnitrosamine	2-aminofluorene promotes the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	19052882
D004052	Diethylnitrosamine	Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA]	22129741
D004052	Diethylnitrosamine	Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein]	15554553
D004052	Diethylnitrosamine	allyl sulfide inhibits the reaction [Diethylnitrosamine results in increased expression of and results in increased activity of GSTP1 protein]	23494807
D004052	Diethylnitrosamine	allyl sulfide inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 mRNA]	23494807
D004052	Diethylnitrosamine	bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 mRNA]	17106253
D004052	Diethylnitrosamine	bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	17106253
D004052	Diethylnitrosamine	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTP1 protein	12725062
D004052	Diethylnitrosamine	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein	12725062
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein	15554553
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA	12497209; 12781041;
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein	12497209; 12781041; 17393424;
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in decreased expression of GSTP1 protein	16246485
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of GSTP1 protein	16246485
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with Cyclohexanols] results in increased expression of GSTP1 protein	17393424
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of GSTP1 protein	18648771
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of GSTP1 mRNA	28943392
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased expression of and results in increased activity of GSTP1 protein	23494807
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased expression of GSTP1 mRNA	17106253; 19638242; 23494807; 24954034; 2559087; 3124819;
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased expression of GSTP1 protein	15526359; 17106253; 19052882; 24954034; 27046949; 28804948;
D004052	Diethylnitrosamine	formylchromone analog inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 mRNA]	24954034
D004052	Diethylnitrosamine	formylchromone analog inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	24954034
D004052	Diethylnitrosamine	geraniol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	27046949
D004052	Diethylnitrosamine	herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA]	12907702
D004052	Diethylnitrosamine	herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein]	12907702
D004052	Diethylnitrosamine	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA	22129741
D004052	Diethylnitrosamine	[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein	20935162
D004052	Diethylnitrosamine	Pioglitazone inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	15526359
D004052	Diethylnitrosamine	Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA]	12497209
D004052	Diethylnitrosamine	Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein]	12497209
D004052	Diethylnitrosamine	Plant Extracts inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	28804948
D004052	Diethylnitrosamine	Rosiglitazone inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	15526359
D004052	Diethylnitrosamine	Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein]	15554553
D004052	Diethylnitrosamine	Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTP1 protein]	12725062
D004052	Diethylnitrosamine	Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein]	12725062
D004052	Diethylnitrosamine	Troglitazone inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	15526359
D004054	Diethylstilbestrol	Diethylstilbestrol inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C015144	dihydrolipoic acid	dihydrolipoic acid promotes the reaction [JUN protein binds to GSTP1 enhancer]	20237067
C015144	dihydrolipoic acid	[dihydrolipoic acid promotes the reaction [JUN protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA	20237067; 20237067;
C015144	dihydrolipoic acid	dihydrolipoic acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]	20237067
C015144	dihydrolipoic acid	[dihydrolipoic acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA	20237067; 20237067;
C015144	dihydrolipoic acid	dihydrolipoic acid results in increased expression of and results in increased activity of GSTP1 protein	20237067
C015144	dihydrolipoic acid	dihydrolipoic acid results in increased expression of GSTP1 mRNA	20237067
C015835	dimethyl-4-toluidine	dimethyl-4-toluidine results in increased expression of GSTP1 mRNA	27638505
D004126	Dimethylformamide	Dimethylformamide results in increased expression of GSTP1 protein	10547960
C024629	dimethyl phthalate	dimethyl phthalate results in increased expression of GSTP1 mRNA	26924002
D004137	Dinitrochlorobenzene	GSTP1 protein affects the metabolism of Dinitrochlorobenzene	14508638
D004137	Dinitrochlorobenzene	GSTP1 protein affects the metabolism of Dinitrochlorobenzene	3592675
D004137	Dinitrochlorobenzene	GSTP1 protein affects the metabolism of Dinitrochlorobenzene	10870112; 15355982;
D004137	Dinitrochlorobenzene	GSTP1 protein SNP binds to and results in increased glutathionylation of Dinitrochlorobenzene	22401947
D004137	Dinitrochlorobenzene	Mercuric Chloride inhibits the reaction [GSTP1 protein SNP binds to and results in increased glutathionylation of Dinitrochlorobenzene]	22401947
D004137	Dinitrochlorobenzene	methylmercuric chloride inhibits the reaction [GSTP1 protein SNP binds to and results in increased glutathionylation of Dinitrochlorobenzene]	22401947
D004137	Dinitrochlorobenzene	Sodium Selenite inhibits the reaction [GSTP1 protein SNP binds to and results in increased glutathionylation of Dinitrochlorobenzene]	22401947
D004137	Dinitrochlorobenzene	Dinitrochlorobenzene results in decreased activity of GSTP1 protein	9794801
D004137	Dinitrochlorobenzene	Dinitrochlorobenzene results in increased expression of GSTP1 protein	9794801
D004137	Dinitrochlorobenzene	GSTP1 protein affects the metabolism of Dinitrochlorobenzene	2619714
D004137	Dinitrochlorobenzene	GSTP1 protein affects the metabolism of Dinitrochlorobenzene	14573868
C051904	dinophysistoxin 1	dinophysistoxin 1 results in increased expression of GSTP1 mRNA	28939011
D004147	Dioxins	Dioxins affects the expression of GSTP1 mRNA	20463971
D004050	Ditiocarb	Ditiocarb results in increased expression of GSTP1 protein	22874009
D004237	Diuron	Diuron results in increased expression of GSTP1 mRNA	21551480
C560357	DLJ14 compound	DLJ14 compound results in decreased expression of GSTP1 mRNA	21402141
C560357	DLJ14 compound	DLJ14 compound results in decreased expression of GSTP1 protein	21402141
D000077143	Docetaxel	GSTP1 mRNA results in increased susceptibility to Docetaxel	15239142
D004298	Dopamine	Dopamine analog results in decreased activity of GSTP1 protein	8131222
C516138	dorsomorphin	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA	27188386
C516138	dorsomorphin	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA	27188386
C516138	dorsomorphin	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA	27188386
D004316	Doxepin	Doxepin results in decreased activity of GSTP1 protein	15094841
D004317	Doxorubicin	Doxorubicin promotes the reaction [GATA1 protein binds to GSTP1 promoter]	14623254
D004317	Doxorubicin	Doxorubicin results in increased expression of GSTP1 mRNA	14623254; 15205334; 15533597; 16579640; 29803840;
D004317	Doxorubicin	Doxorubicin results in increased expression of GSTP1 protein	14623254
D004317	Doxorubicin	[GCLC protein co-treated with GCLM protein] promotes the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin]	10900222
D004317	Doxorubicin	GSTP1 gene SNP results in increased susceptibility to [Carmustine co-treated with Doxorubicin co-treated with Cyclophosphamide co-treated with Melphalan]	12791655
D004317	Doxorubicin	GSTP1 mRNA results in decreased susceptibility to Doxorubicin	15448748
D004317	Doxorubicin	GSTP1 promoter modified form results in decreased susceptibility to Doxorubicin	16356834
D004317	Doxorubicin	GSTP1 protein affects the susceptibility to Doxorubicin	16217747; 18225754;
D004317	Doxorubicin	GSTP1 protein results in decreased susceptibility to Doxorubicin	24675091
D004317	Doxorubicin	Haloperidol inhibits the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin]	15946544
D004317	Doxorubicin	[copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of GSTP1 protein] which results in increased susceptibility to Doxorubicin	16289015
D004317	Doxorubicin	Doxorubicin results in decreased expression of GSTP1 protein	29775573
D004317	Doxorubicin	GSTP1 protein results in decreased susceptibility to Doxorubicin	16289015
D004317	Doxorubicin	indole-3-carbinol inhibits the reaction [Doxorubicin results in decreased expression of GSTP1 protein]	29775573
D004317	Doxorubicin	GSTP1 protein results in decreased susceptibility to Doxorubicin	12964789
D004317	Doxorubicin	[Doxorubicin results in increased expression of NFE2L2 protein] which results in increased expression of GSTP1 mRNA	24211725
D004317	Doxorubicin	Doxorubicin results in increased oxidation of GSTP1 protein	28818578
D004317	Doxorubicin	GSTP1 protein results in decreased susceptibility to Doxorubicin	11455017
D004318	Doxycycline	Doxycycline inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042986	ebselen	ebselen binds to and results in decreased activity of GSTP1 protein	8147899
D004464	Econazole	Econazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D015118	Eicosapentaenoic Acid	Eicosapentaenoic Acid results in decreased expression of GSTP1 protein	22830632
C108024	emamectin benzoate	emamectin benzoate results in increased expression of GSTP1 mRNA	18786259
D004642	Emodin	Emodin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA]	15313406
D004642	Emodin	Emodin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA]	15313406
D004726	Endosulfan	Endosulfan results in increased expression of GSTP1 mRNA	29391264
D015365	Enoxacin	Enoxacin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D004785	Environmental Pollutants	Environmental Pollutants results in increased expression of GSTP1 mRNA	25187966
D004791	Enzyme Inhibitors	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GSTP1 protein	23301498
C045651	epigallocatechin gallate	epigallocatechin gallate results in decreased expression of GSTP1 mRNA	18851785
C109476	epoxiconazole	epoxiconazole results in increased expression of GSTP1 mRNA	25182419
D004857	Equilin	Equilin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D004878	Ergotamine	Ergotamine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C007619	eriodictyol	eriodictyol results in decreased activity of GSTP1 protein	15041478
D004923	Erythrosine	Erythrosine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D004958	Estradiol	Estradiol results in decreased expression of GSTP1 mRNA	30248606
D004958	Estradiol	Estradiol analog inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D004958	Estradiol	Estradiol inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D004958	Estradiol	Estradiol results in decreased expression of GSTP1 mRNA	17982697
D004958	Estradiol	Estradiol results in decreased expression of GSTP1 mRNA	31119341
C007630	estradiol 17 beta-cypionate	estradiol 17 beta-cypionate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D004976	Ethacrynic Acid	Ethacrynic Acid analog results in decreased activity of GSTP1 protein	15911318
D004976	Ethacrynic Acid	Ethacrynic Acid binds to and results in decreased activity of GSTP1 protein	9463521
D004976	Ethacrynic Acid	Ethacrynic Acid inhibits the reaction [Chlorophyllides inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]]	23769903
D004976	Ethacrynic Acid	Ethacrynic Acid inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin]	9806904
D004976	Ethacrynic Acid	Ethacrynic Acid inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide]	15999103
D004976	Ethacrynic Acid	Ethacrynic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D004976	Ethacrynic Acid	Ethacrynic Acid results in decreased activity of GSTP1 protein	15911318
D004976	Ethacrynic Acid	Ethacrynic Acid results in increased expression of GSTP1 protein	14556662
D004976	Ethacrynic Acid	GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP3 protein]	23082001
D004976	Ethacrynic Acid	GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein]	23082001
D004976	Ethacrynic Acid	GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]	23082001
D004976	Ethacrynic Acid	GSTP1 protein affects the metabolism of Ethacrynic Acid analog	12781783
D004976	Ethacrynic Acid	GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Ethacrynic Acid]	10900222
D004976	Ethacrynic Acid	GSTP1 protein results in decreased susceptibility to [Arsenic Trioxide co-treated with Ethacrynic Acid]	23082001
D004976	Ethacrynic Acid	GSTP1 protein results in decreased susceptibility to Ethacrynic Acid	10900222; 2747627;
D004976	Ethacrynic Acid	Pyrimethamine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]	11807801
D004976	Ethacrynic Acid	Quinidine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]	11807801
D004976	Ethacrynic Acid	Quinine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]	11807801
D004976	Ethacrynic Acid	Tetracycline inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]	11807801
D004976	Ethacrynic Acid	GSTP1 protein affects the metabolism of Ethacrynic Acid	2619714; 9877184;
D004976	Ethacrynic Acid	Ethacrynic Acid results in decreased activity of GSTP1 protein	11455017
D000431	Ethanol	Ethanol affects the splicing of GSTP1 mRNA	30319688
D000431	Ethanol	Ethanol results in decreased expression of GSTP1 mRNA	28119953
D000431	Ethanol	Ethanol results in decreased expression of GSTP1 protein	28119953
D000431	Ethanol	Ethanol results in increased expression of GSTP1 mRNA	23273579
D000431	Ethanol	Ethanol results in increased expression of GSTP1 protein	18271918
D004997	Ethinyl Estradiol	Ethinyl Estradiol affects the expression of GSTP1 mRNA	25064622
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in decreased expression of GSTP1 mRNA	23550701
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in decreased expression of GSTP1 mRNA	23129252
D005015	Ethoxyquin	Ethoxyquin results in increased expression of GSTP1 mRNA	19695238
D005015	Ethoxyquin	Ethoxyquin results in increased expression of GSTP1 protein	8198522; 9794803;
C004912	ethylbenzene	ethylbenzene results in decreased activity of GSTP1 protein	18409811
C024565	ethylene dichloride	ethylene dichloride results in decreased expression of GSTP1 mRNA	28189721
D005031	Ethylenethiourea	Ethylenethiourea results in increased expression of GSTP1 mRNA	18801409
D005047	Etoposide	Curcumin inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide]	15999103
D005047	Etoposide	Ethacrynic Acid inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide]	15999103
D005047	Etoposide	GSTP1 gene polymorphism affects the susceptibility to Etoposide	12969965
D005047	Etoposide	GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Etoposide]	10900222
D005047	Etoposide	GSTP1 protein results in decreased susceptibility to Etoposide	10900222; 15999103;
D005047	Etoposide	Sulfinpyrazone inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide]	15999103
D005047	Etoposide	verlukast inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide]	15999103
D005054	Eugenol	Eugenol analog results in decreased activity of GSTP1 protein	8620581
D015525	Fatty Acids, Omega-3	GSTP1 gene polymorphism affects the susceptibility to Fatty Acids, Omega-3	15256483
D005273	Fenbendazole	Fenbendazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D011345	Fenofibrate	Fenofibrate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C082360	fipronil	fipronil results in increased expression of GSTP1 mRNA	23962444
D005419	Flavonoids	Flavonoids results in decreased expression of GSTP1 mRNA	15465739
D005439	Flufenamic Acid	Flufenamic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D005444	Flunarizine	Flunarizine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D005447	Fluocinonide	Fluocinonide inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C007738	fluoranthene	[Benzo(a)pyrene co-treated with fluoranthene] affects the expression of GSTP1 mRNA	25412620
C007738	fluoranthene	fluoranthene results in increased expression of GSTP1 mRNA	18522720
D005472	Fluorouracil	[Cisplatin co-treated with Fluorouracil] results in decreased expression of GSTP1 mRNA	15737843
D005472	Fluorouracil	Fluorouracil results in increased expression of GSTP1 mRNA	15205334
D005472	Fluorouracil	GSTP1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with Oxaliplatin]	15213713
D005472	Fluorouracil	GSTP1 gene polymorphism results in decreased susceptibility to [Fluorouracil co-treated with Cisplatin]	16622263
D005481	Flurothyl	Flurothyl inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D005485	Flutamide	Flutamide inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D005485	Flutamide	Flutamide results in increased expression of GSTP1 mRNA	24136188
D005492	Folic Acid	Folic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D005557	Formaldehyde	Formaldehyde results in increased expression of GSTP1 mRNA	18045764
D005557	Formaldehyde	Formaldehyde results in increased expression of GSTP1 protein	18045764
C502480	formylchromone	formylchromone analog inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 mRNA]	24954034
C502480	formylchromone	formylchromone analog inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	24954034
D005648	Fuel Oils	Fuel Oils results in increased expression of GSTP1 mRNA	20821661
C039281	furan	furan results in increased expression of GSTP1 mRNA	20124500; 25539665; 26194646; 27387713;
C037032	galangin	galangin results in decreased activity of GSTP1 protein	15041478
C096329	gamma-Glu-S-BzCys-PhGly diethyl ester	gamma-Glu-S-BzCys-PhGly diethyl ester inhibits the reaction [GSTP1 protein results in increased susceptibility to Deoxycholic Acid]	15300575
C050159	gamma-glutamyl-glutathione	GSTP1 protein binds to and affects the metabolism of gamma-glutamyl-glutathione	2619714
D019833	Genistein	Genistein results in decreased expression of GSTP1 mRNA	24967385
D005839	Gentamicins	Gentamicins results in decreased expression of GSTP1 mRNA	20623750
D005840	Gentian Violet	Gentian Violet inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C007836	geraniol	geraniol inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	27046949
D005978	Glutathione	[CYP1A1 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP1A2 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP1B1 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP2A6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP2B6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP2B6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
D005978	Glutathione	[CYP2C18 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP2C18 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
D005978	Glutathione	[CYP2C19 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP2C19 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
D005978	Glutathione	[CYP2C8 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac	24246759
D005978	Glutathione	[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac	24246759
D005978	Glutathione	[[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac	24246759
D005978	Glutathione	[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased metabolism of Diclofenac	24246759
D005978	Glutathione	[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac	24246759
D005978	Glutathione	[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
D005978	Glutathione	[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac	24246759
D005978	Glutathione	[[CYP2D6 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac	24246759
D005978	Glutathione	[CYP2E1 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP2J2 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
D005978	Glutathione	[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of Diclofenac	24246759
D005978	Glutathione	[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac	24246759
D005978	Glutathione	[[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 5-hydroxydiclofenac	24246759
D005978	Glutathione	[CYP3A5 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac	24246759
D005978	Glutathione	[CYP3A5 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac	24246759
D005978	Glutathione	Glutathione analog results in decreased activity of GSTP1 protein	13679171
D005978	Glutathione	GSTP1 gene affects the reaction [Glutathione affects the metabolism of Thiotepa]	10334868
D005978	Glutathione	GSTP1 protein affects the metabolism of [4-oxo-2-nonenal co-treated with Glutathione]	15528046
D005978	Glutathione	GSTP1 protein affects the metabolism of [6-bromoacetyl-2-dimethylaminonaphthalene co-treated with Glutathione]	12470677
D005978	Glutathione	GSTP1 protein affects the metabolism of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione]	9403173
D005978	Glutathione	GSTP1 protein affects the metabolism of [acrylodan co-treated with Glutathione]	12470677
D005978	Glutathione	GSTP1 protein affects the metabolism of and results in decreased activity of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione]	11849043
D005978	Glutathione	GSTP1 protein affects the metabolism of and results in decreased activity of [dibenzo(a,l)pyrene co-treated with Glutathione]	11849043
D005978	Glutathione	GSTP1 protein affects the metabolism of [Atrazine co-treated with Glutathione]	15115887
D005978	Glutathione	GSTP1 protein affects the metabolism of [benzo(c)chrysene co-treated with Glutathione]	9403173
D005978	Glutathione	GSTP1 protein affects the metabolism of [benzo(c)phenanthrene co-treated with Glutathione]	9403173
D005978	Glutathione	GSTP1 protein affects the metabolism of [benzo(g)chrysene co-treated with Glutathione]	9403173
D005978	Glutathione	GSTP1 protein affects the metabolism of Glutathione	7826396; 8886613;
D005978	Glutathione	GSTP1 protein affects the metabolism of [hydratropic aldehyde co-treated with Glutathione]	11368548
D005978	Glutathione	GSTP1 protein affects the metabolism of [Thiotepa co-treated with Glutathione]	7712478
D005978	Glutathione	[GSTP1 protein co-treated with Glutathione] inhibits the reaction [Adenosine Triphosphate results in increased activity of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine]	11196146
D005978	Glutathione	[GSTP1 protein co-treated with Glutathione] inhibits the reaction [[Adenosine Triphosphate results in increased metabolism of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine] which results in increased abundance of 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct]	11196146
D005978	Glutathione	[GSTP1 protein co-treated with Glutathione] results in increased metabolism of amodiaquine quinoneimine	28478157
D005978	Glutathione	[GSTP1 protein co-treated with Glutathione] results in increased metabolism of desethylamodiaquine	28478157
D005978	Glutathione	GSTP1 protein promotes the reaction [Glutathione binds to Atrazine]	18607078
D005978	Glutathione	Ketoconazole inhibits the reaction [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac]	24246759
D005978	Glutathione	Ketoconazole inhibits the reaction [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac]	24246759
D005978	Glutathione	Sulfaphenazole inhibits the reaction [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac]	24246759
D005978	Glutathione	Glutathione deficiency results in increased expression of GSTP1 mRNA	20621112
D005978	Glutathione	Glutathione inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of GSTP1 protein]	20570720
D005978	Glutathione	GSTP1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione]	8973562
D005978	Glutathione	GSTP1 protein affects the metabolism of Glutathione	9877184
D005978	Glutathione	GSTP1 protein affects the metabolism of [monobromobimane co-treated with Glutathione]	14573868
C004333	goitrin	goitrin results in decreased expression of GSTP1 protein	7532609
C004333	goitrin	goitrin results in increased expression of GSTP1 protein	7532609
C004333	goitrin	Triiodothyronine inhibits the reaction [goitrin results in increased expression of GSTP1 protein]	7532609
D006096	Gramicidin	Gramicidin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C053526	halazone	halazone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D006220	Haloperidol	Haloperidol inhibits the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin]	15946544
D006220	Haloperidol	Haloperidol results in decreased expression of GSTP1 mRNA	15946544
D006427	Hemin	Hemin results in increased stability of and results in increased expression of GSTP1 mRNA	15313425
C476499	herbal compound 861	herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA]	12907702
C476499	herbal compound 861	herbal compound 861 inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein]	12907702
D006540	Herbicides	Herbicides results in increased expression of GSTP1 mRNA	29458080
D006540	Herbicides	GSTP1 gene polymorphism affects the susceptibility to Herbicides	17190945
D006540	Herbicides	GSTP1 protein results in increased susceptibility to Herbicides	17190945
D006581	Hexachlorobenzene	Hexachlorobenzene results in increased expression of GSTP1 protein	10696772; 9630449;
D006582	Hexachlorophene	Hexachlorophene inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C027765	hexamethylene glycol	hexamethylene glycol inhibits the reaction [GSTP1 protein binds to GSTP1 protein]	16401067
C033550	hexylglutathione	hexylglutathione inhibits the reaction [captafol results in decreased activity of GSTP1 protein]	8678907
C033550	hexylglutathione	hexylglutathione inhibits the reaction [Captan results in decreased activity of GSTP1 protein]	8678907
C060446	homosalate	homosalate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D006830	Hydralazine	Hydralazine results in decreased methylation of GSTP1 promoter	15862127
D006830	Hydralazine	Hydralazine results in increased expression of GSTP1 mRNA	15862127
C013026	hydratropic aldehyde	GSTP1 protein affects the metabolism of [hydratropic aldehyde co-treated with Glutathione]	11368548
C013026	hydratropic aldehyde	GSTP1 protein results in decreased activity of hydratropic aldehyde	11368548
C013026	hydratropic aldehyde	hydratropic aldehyde results in decreased activity of GSTP1 protein	11368548
D006841	Hydrocarbons, Aromatic	GSTP1 protein affects the metabolism of Hydrocarbons, Aromatic	12359356
D006861	Hydrogen Peroxide	GSTP1 protein results in decreased susceptibility to Hydrogen Peroxide	15528046
D006861	Hydrogen Peroxide	GSTP1 protein results in increased degradation of and results in decreased susceptibility to Hydrogen Peroxide	15231573
D006861	Hydrogen Peroxide	Hydrogen Peroxide affects the localization of GSTP1 protein	15528046
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in decreased expression of GSTP1 mRNA	12419474
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in decreased expression of GSTP1 protein	15832819
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased expression of GSTP1 mRNA	15056853; 15533597;
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased expression of GSTP1 protein	15056853
D006861	Hydrogen Peroxide	GSTP1 protein results in decreased susceptibility to Hydrogen Peroxide	15386426
D006861	Hydrogen Peroxide	GSTP1 protein results in decreased abundance of Hydrogen Peroxide	15231573
C012353	hydroperoxyisophosphamide	GSTP1 gene affects the susceptibility to hydroperoxyisophosphamide	12360105
D006919	Hydroxyzine	Hydroxyzine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C004965	hypericin	hypericin binds to and results in decreased activity of GSTP1 protein	15461448
C004965	hypericin	hypericin results in decreased activity of GSTP1 protein	20637187
D007052	Ibuprofen	Ibuprofen results in increased expression of GSTP1 mRNA	22559005
C492448	ICG 001	ICG 001 results in increased expression of GSTP1 mRNA	26191083
D007069	Ifosfamide	GSTP1 gene polymorphism affects the susceptibility to Ifosfamide	12868187
D007069	Ifosfamide	GSTP1 gene polymorphism results in increased susceptibility to Ifosfamide	16282887
D007099	Imipramine	Imipramine results in decreased activity of GSTP1 protein	15094841
C093581	indene	indene results in increased expression of GSTP1 mRNA	27750016
C428264	indioside D	indioside D results in increased expression of GSTP1 protein	18376857
C027185	indirubin	indirubin results in increased expression of GSTP1 mRNA	15056799
C016517	indole-3-carbinol	indole-3-carbinol inhibits the reaction [Doxorubicin results in decreased expression of GSTP1 protein]	29775573
C016517	indole-3-carbinol	Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA]	22129741
C016517	indole-3-carbinol	indole-3-carbinol affects the expression of GSTP1 mRNA	21396975
C016517	indole-3-carbinol	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA	22129741
C016517	indole-3-carbinol	indole-3-carbinol results in increased expression of GSTP1 protein	9794803
D004103	Iodoquinol	Iodoquinol inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D015759	Ionomycin	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GSTP1 mRNA	25613284
C489556	isoline	isoline results in increased expression of GSTP1 protein	24641316
C031050	isomethyleugenol	isomethyleugenol results in decreased activity of GSTP1 protein	8620581
D007538	Isoniazid	Isoniazid results in decreased expression of GSTP1 mRNA	20623750
C015304	isopimpinellin	isopimpinellin results in increased expression of GSTP1 mRNA	18692084
D017879	Isothiocyanates	GSTP1 gene SNP affects the susceptibility to Isothiocyanates	14693750
D015474	Isotretinoin	Ethacrynic Acid inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin]	9806904
D015474	Isotretinoin	GSTP1 protein affects the metabolism of Isotretinoin	9806904
D015474	Isotretinoin	S-decylglutathione inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin]	9806904
D017964	Itraconazole	Itraconazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C006552	kaempferol	kaempferol results in decreased activity of GSTP1 protein	15041478
C053401	kahweol	[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTP1 protein]	17110534
D007648	Kerosene	Kerosene results in increased expression of GSTP1 mRNA	20821661
D007654	Ketoconazole	Ketoconazole inhibits the reaction [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac]	24246759
D007654	Ketoconazole	Ketoconazole inhibits the reaction [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 5-hydroxydiclofenac]	24246759
D064747	Lansoprazole	Lansoprazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D007854	Lead	GSTP1 gene polymorphism affects the reaction [Lead results in increased expression of CRP protein]	23484121
D007854	Lead	GSTP1 gene polymorphism affects the susceptibility to Lead	23484121
D007854	Lead	GSTP1 protein polymorphism affects the susceptibility to Lead	23958642
C008261	lead acetate	lead acetate results in increased expression of GSTP1 mRNA	29746905
C008261	lead acetate	lead acetate affects the localization of GSTP1 protein	9750042
C008261	lead acetate	lead acetate results in increased expression of GSTP1 mRNA	9750042
C008261	lead acetate	lead acetate results in increased expression of GSTP1 protein	7878682; 9750042;
C029891	lead chloride	lead chloride results in increased expression of GSTP1 mRNA	17961207
D000077339	Leflunomide	Leflunomide results in increased expression of GSTP1 mRNA	28988120
D000077339	Leflunomide	Leflunomide results in increased expression of GSTP1 mRNA	24136188
C482199	lipopolysaccharide, E coli O55-B5	[lipopolysaccharide, E coli O55-B5 co-treated with Benzo(a)pyrene] affects the expression of GSTP1 mRNA	28987381
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of GSTP1 mRNA	24001438
D008070	Lipopolysaccharides	Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of GSTP1 mRNA]	24001438
D008070	Lipopolysaccharides	GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]	16023107
D008070	Lipopolysaccharides	GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]	16023107
D008070	Lipopolysaccharides	GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein]	16023107
D008070	Lipopolysaccharides	GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]	16023107
D008070	Lipopolysaccharides	GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]	16023107
D008070	Lipopolysaccharides	GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein]	16023107
D008070	Lipopolysaccharides	GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]	16023107
D008070	Lipopolysaccharides	GSTP1 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]	16023107
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of GSTP1 mRNA	16023107
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of GSTP1 protein	16023107
D008070	Lipopolysaccharides	Lipopolysaccharides results in decreased expression of GSTP1 mRNA	25613284
D008094	Lithium	Lithium results in increased expression of GSTP1 protein	18296634
D008344	Maneb	[Maneb co-treated with Paraquat] results in decreased expression of GSTP1 mRNA	23963992
D008344	Maneb	Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of GSTP1 mRNA]	23963992
D008344	Maneb	Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of GSTP1 mRNA]	23963992
D008345	Manganese	GSTP1 gene polymorphism affects the susceptibility to Manganese	30930959
D008463	Mebendazole	Mebendazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D008468	Meclizine	Meclizine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D020926	Medetomidine	Medetomidine results in decreased expression of GSTP1 mRNA	21703361
D008528	Mefenamic Acid	GSTP1 protein results in increased glutathionylation of Mefenamic Acid analog	25372302
D008550	Melatonin	Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of GSTP1 mRNA]	23963992
D008550	Melatonin	Melatonin affects the reaction [Dexamethasone results in decreased expression of GSTP1 mRNA]	21986892
D008558	Melphalan	GSTP1 gene SNP results in increased susceptibility to [Carmustine co-treated with Doxorubicin co-treated with Cyclophosphamide co-treated with Melphalan]	12791655
D008558	Melphalan	Melphalan inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D008622	Merbromin	Merbromin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C042720	mercuric bromide	mercuric bromide results in increased expression of GSTP1 mRNA	26272509
C042720	mercuric bromide	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA	27188386
D008627	Mercuric Chloride	Mercuric Chloride affects the expression of GSTP1 mRNA	20353558
D008627	Mercuric Chloride	GSTP1 protein SNP affects the susceptibility to Mercuric Chloride	22401947
D008627	Mercuric Chloride	Mercuric Chloride inhibits the reaction [GSTP1 protein SNP binds to and results in increased glutathionylation of Dinitrochlorobenzene]	22401947
D008628	Mercury	GCLC gene polymorphism promotes the reaction [GSTP1 gene polymorphism affects the abundance of Mercury]	19515364
D008628	Mercury	GSTP1 gene affects the abundance of Mercury	18560528
D008628	Mercury	GSTP1 gene polymorphism affects the abundance of Mercury	19515364; 21967774;
D008628	Mercury	[GSTP1 gene polymorphism co-treated with GSTM1 gene polymorphism] affects the abundance of Mercury	19515364
D008628	Mercury	GSTT1 gene polymorphism promotes the reaction [GSTP1 gene polymorphism affects the abundance of Mercury]	19515364
D008628	Mercury	Mercury results in increased expression of GSTP1 mRNA	12167210; 12730625;
D008628	Mercury	Mercury results in increased expression of GSTP1 protein	12167210; 12730625;
D008628	Mercury	Mercury results in increased expression of GSTP1 protein	18198945
D015080	Mesna	Mesna inhibits the reaction [GSTP1 protein affects the reaction [Cyclophosphamide results in increased phosphorylation of MAPK8 protein]]	19696094
D008687	Metformin	Metformin results in increased expression of GSTP1 mRNA	19022234
D008694	Methamphetamine	GSTP1 exon polymorphism results in increased susceptibility to Methamphetamine	15729709
D008701	Methapyrilene	Methapyrilene results in increased expression of GSTP1 mRNA	30467583
C005219	methyl cellosolve	methyl cellosolve results in increased expression of GSTP1 mRNA	16141653; 21061450;
D008748	Methylcholanthrene	Methylcholanthrene results in increased expression of GSTP1 mRNA	19118567; 23273579;
D008750	Methyldopa	Methyldopa analog results in decreased activity of GSTP1 protein	8131222
D008751	Methylene Blue	Methylene Blue inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C005223	methyleugenol	methyleugenol results in decreased activity of GSTP1 protein	8620581
C004925	methylmercuric chloride	methylmercuric chloride results in increased expression of GSTP1 mRNA	17961207; 23458150;
C004925	methylmercuric chloride	methylmercuric chloride results in increased expression of GSTP1 mRNA	23103053
C004925	methylmercuric chloride	GSTP1 protein SNP affects the susceptibility to methylmercuric chloride	22401947
C004925	methylmercuric chloride	GSTP1 results in decreased susceptibility to methylmercuric chloride	28184905
C004925	methylmercuric chloride	methylmercuric chloride inhibits the reaction [GSTP1 protein SNP binds to and results in increased glutathionylation of Dinitrochlorobenzene]	22401947
C004925	methylmercuric chloride	methylmercuric chloride results in increased expression of GSTP1 mRNA	28001369
D008767	Methylmercury Compounds	Methylmercury Compounds results in increased expression of GSTP1 mRNA	27544571
D008767	Methylmercury Compounds	GSTP1 protein affects the metabolism of Methylmercury Compounds	18560528
D008769	Methylnitronitrosoguanidine	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of GSTP1 mRNA	19840844
D008769	Methylnitronitrosoguanidine	[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of GSTP1 mRNA	19840844
D008769	Methylnitronitrosoguanidine	[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GSTP1 mRNA	19840844
C063855	microcystin RR	GSTP1 protein results in increased glutathionylation of microcystin RR	23538035
D052998	Microcystins	Buthionine Sulfoximine inhibits the reaction [Microcystins analog results in increased expression of GSTP1 mRNA]	24964298
D052998	Microcystins	Microcystins affects the expression of GSTP1 mRNA	19790251
D052998	Microcystins	Microcystins analog results in increased expression of GSTP1 mRNA	24964298
D052998	Microcystins	Microcystins results in increased expression of GSTP1 mRNA	19790251
D016685	Mitomycin	GSTP1 mRNA results in increased susceptibility to Mitomycin	15239142
D016685	Mitomycin	Mitomycin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D016685	Mitomycin	GSTP1 protein results in decreased susceptibility to Mitomycin	12964789
D008939	Mitotane	Mitotane inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in decreased expression of GSTP1 mRNA	29277029
C028381	monobromobimane	GSTP1 protein affects the metabolism of monobromobimane	15355982
C028381	monobromobimane	GSTP1 protein affects the metabolism of [monobromobimane co-treated with Glutathione]	14573868
C028381	monobromobimane	monobromobimane results in decreased activity of GSTP1 protein	14573868
D008999	Monocrotophos	[Monocrotophos co-treated with Cimetidine] results in increased expression of GSTP1 protein	22733800
D008999	Monocrotophos	Monocrotophos results in increased expression of GSTP1 mRNA	22733800
D008999	Monocrotophos	Monocrotophos results in increased expression of GSTP1 protein	22733800
D008999	Monocrotophos	[Rifampin co-treated with Monocrotophos] results in increased expression of GSTP1 mRNA	22733800
D008999	Monocrotophos	[Rifampin co-treated with Monocrotophos] results in increased expression of GSTP1 protein	22733800
D008999	Monocrotophos	Monocrotophos results in increased expression of GSTP1 mRNA	21445290
D008999	Monocrotophos	Monocrotophos results in increased expression of GSTP1 protein	21445290
C020300	monomethylarsonic acid	monomethylarsonic acid results in increased expression of GSTP1 mRNA	17481689
C517284	monomethyl phthalate	monomethyl phthalate results in increased expression of GSTP1 mRNA	26924002
C568376	MT19c compound	MT19c compound results in decreased expression of GSTP1 mRNA	21781307
C500085	muraglitazar	muraglitazar results in decreased expression of GSTP1 mRNA	21515302
C028473	N-acetyl-4-benzoquinoneimine	GSTP1 protein polymorphism affects the metabolism of N-acetyl-4-benzoquinoneimine metabolite	24185126
C028473	N-acetyl-4-benzoquinoneimine	GSTP1 protein results in increased glutathionylation of N-acetyl-4-benzoquinoneimine	24552538
C028473	N-acetyl-4-benzoquinoneimine	GSTP1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine	24185126
C028473	N-acetyl-4-benzoquinoneimine	NQO1 protein inhibits the reaction [GSTP1 protein results in increased glutathionylation of N-acetyl-4-benzoquinoneimine]	24552538
D037742	Nanotubes, Carbon	Nanotubes, Carbon results in increased methylation of GSTP1 gene	29426343
D037742	Nanotubes, Carbon	Nanotubes, Carbon analog results in decreased expression of GSTP1 mRNA	25620056
D037742	Nanotubes, Carbon	Nanotubes, Carbon results in decreased expression of GSTP1 mRNA	25620056
C031721	naphthalene	naphthalene metabolite binds to GSTP1 protein	16453347
C031721	naphthalene	naphthalene results in decreased expression of GSTP1 mRNA	31020322
C031721	naphthalene	naphthalene results in increased expression of GSTP1 protein	10959795
C005274	naringin	[naringin co-treated with 3-nitropropionic acid] results in increased expression of GSTP1 mRNA	22871521
C005274	naringin	naringin results in increased expression of GSTP1 mRNA	22871521
C051752	nefazodone	nefazodone results in increased expression of GSTP1 mRNA	24136188
D009498	Neurotoxins	GSTP1 protein polymorphism affects the susceptibility to Neurotoxins	9802272
D019829	Nevirapine	GSTP1 protein results in increased glutathionylation of Nevirapine metabolite	27989146
D009534	Niclosamide	Niclosamide results in increased expression of GSTP1 mRNA	31398420
D009543	Nifedipine	Nifedipine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C012655	nimesulide	nimesulide results in increased expression of GSTP1 mRNA	24136188
D015737	Nisoldipine	Nisoldipine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D009568	Nitrendipine	Nitrendipine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D009585	Nitrogen Dioxide	GSTP1 gene polymorphism affects the susceptibility to Nitrogen Dioxide	22732554
D009589	Nitrogen Oxides	GSTP1 gene SNP affects the susceptibility to Nitrogen Oxides	18709160
D018817	N-Methyl-3,4-methylenedioxyamphetamine	N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [sulforafan results in increased expression of GSTP1 mRNA]	21871945
D018817	N-Methyl-3,4-methylenedioxyamphetamine	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GSTP1 mRNA	21871945
D018817	N-Methyl-3,4-methylenedioxyamphetamine	sulforafan inhibits the reaction [N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GSTP1 mRNA]	21871945
C012103	N,N-dimethyl-4-(6-benzothiazolylazo)aniline	N,N-dimethyl-4-(6-benzothiazolylazo)aniline results in increased expression of GSTP1 mRNA	3124819
C002741	N-nitrosomorpholine	N-nitrosomorpholine results in increased expression of GSTP1 mRNA	19716841
C002741	N-nitrosomorpholine	N-nitrosomorpholine results in increased expression of GSTP1 protein	19716841
C025256	nonylphenol	nonylphenol results in increased expression of GSTP1 mRNA	19167021
C510003	nordy	nordy results in increased expression of GSTP1 protein	18232056
C464660	obeticholic acid	obeticholic acid results in decreased expression of GSTP1 mRNA	27939613
C025589	ochratoxin A	[cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GSTP1 protein]	17110534
C025589	ochratoxin A	ochratoxin A inhibits the reaction [NFE2L2 protein binds to GSTP1 protein]	17110534
C025589	ochratoxin A	ochratoxin A results in decreased expression of GSTP1 mRNA	12700408; 23358140;
C025589	ochratoxin A	ochratoxin A results in decreased expression of GSTP1 protein	17110534
D019319	Okadaic Acid	Okadaic Acid results in increased expression of GSTP1 mRNA	28939011
D019319	Okadaic Acid	[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of GSTP1 mRNA	19840844
C026209	oltipraz	oltipraz results in increased expression of and results in increased activity of GSTP1 protein	16950796
C026209	oltipraz	oltipraz results in increased expression of GSTP1 mRNA	15374950
C026209	oltipraz	oltipraz results in increased expression of GSTP1 protein	9794803
D009853	Omeprazole	Omeprazole results in increased expression of GSTP1 mRNA	19118567
D009966	Orphenadrine	Orphenadrine affects the expression of GSTP1 mRNA	23665939
D000077150	Oxaliplatin	GSTP1 gene polymorphism affects the susceptibility to [Fluorouracil co-treated with Oxaliplatin]	15213713
D000077150	Oxaliplatin	GSTP1 gene polymorphism affects the susceptibility to Oxaliplatin	20979931
D000077150	Oxaliplatin	GSTP1 gene SNP affects the susceptibility to Oxaliplatin	17401013
D000077150	Oxaliplatin	GSTP1 protein affects the susceptibility to Oxaliplatin	16773204
D000077150	Oxaliplatin	GSTP1 protein results in decreased activity of Oxaliplatin	15655543
D000077150	Oxaliplatin	GSTP1 protein results in decreased susceptibility to Oxaliplatin	15655543
D000077150	Oxaliplatin	Oxaliplatin results in increased expression of GSTP1 mRNA	16773204
C011321	oxibendazole	oxibendazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C022155	oxiconazole	oxiconazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D016627	Oxidopamine	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of GSTP1 protein]]	25271104
D016627	Oxidopamine	GSTP1 mutant form inhibits the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of GSTP1 protein]]	25271104; 25271104;
D016627	Oxidopamine	GSTP1 mutant form inhibits the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of CASP3 protein]]	25271104
D016627	Oxidopamine	Oxidopamine results in decreased expression of GSTP1 protein	25271104
D016627	Oxidopamine	salvin inhibits the reaction [Oxidopamine results in decreased expression of GSTP1 protein]	25271104
C029341	oxophenylarsine	oxophenylarsine binds to GSTP1 protein	12519079
C005290	oxybenzone	oxybenzone results in increased expression of GSTP1 mRNA	30316929
D010100	Oxygen	Oxygen results in increased expression of GSTP1 mRNA	22911455
D010113	Oxyphenbutazone	Oxyphenbutazone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D010126	Ozone	GSTP1 gene polymorphism affects the susceptibility to Ozone	22732554
D010126	Ozone	GSTP1 gene SNP affects the reaction [MS4A2 gene SNP affects the susceptibility to Ozone]	18269668
D010126	Ozone	GSTP1 gene SNP affects the reaction [TNF gene SNP affects the susceptibility to Ozone]	16456144
D010126	Ozone	GSTP1 gene SNP promotes the reaction [HMOX1 gene SNP results in increased susceptibility to Ozone]	18524839
D010126	Ozone	GSTP1 gene SNP results in increased susceptibility to Ozone	16870661; 17652311; 18524839;
D017239	Paclitaxel	GSTP1 mRNA results in increased susceptibility to Paclitaxel	15239142
D017239	Paclitaxel	GSTP1 protein affects the susceptibility to Paclitaxel	16217747
C530734	p-aminophenylarsine oxide	p-aminophenylarsine oxide binds to GSTP1 protein	22422341
D010269	Paraquat	Paraquat affects the expression of GSTP1 mRNA	25064622
D010269	Paraquat	Dapsone inhibits the reaction [Paraquat results in decreased expression of GSTP1 protein]	21765237
D010269	Paraquat	[Maneb co-treated with Paraquat] results in decreased expression of GSTP1 mRNA	23963992
D010269	Paraquat	Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of GSTP1 mRNA]	23963992
D010269	Paraquat	Paraquat results in decreased expression of GSTP1 protein	21765237
D010269	Paraquat	Paraquat results in increased expression of GSTP1 mRNA	16128001; 18620719;
D010269	Paraquat	Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of GSTP1 mRNA]	23963992
C005409	pararosaniline	pararosaniline inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D010278	Parathion	Parathion results in increased expression of GSTP1 mRNA	17982697
D052638	Particulate Matter	GSTP1 gene polymorphism affects the susceptibility to Particulate Matter	20656020; 22732554;
D052638	Particulate Matter	Particulate Matter results in increased expression of GSTP1 mRNA	18952161
D052638	Particulate Matter	Particulate Matter analog results in increased expression of GSTP1 mRNA	12011483
D052638	Particulate Matter	Particulate Matter results in increased expression of GSTP1 mRNA	22352393
D052638	Particulate Matter	Particulate Matter results in increased expression of GSTP1 protein	18474546
C003060	pentachlorobenzene	pentachlorobenzene results in increased expression of GSTP1 protein	10696772; 9630449;
D010416	Pentachlorophenol	Pentachlorophenol results in increased expression of GSTP1 mRNA	24642059
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid affects the expression of GSTP1 mRNA	19429403
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased expression of GSTP1 mRNA	20621739
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased methylation of GSTP1 promoter	20621739
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased expression of GSTP1 mRNA	18424238
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased methylation of GSTP1 promoter	22425687
C023036	perfluorooctanoic acid	perfluorooctanoic acid affects the expression of GSTP1 mRNA	19429403
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased expression of GSTP1 mRNA	18467677; 20936131;
C023036	perfluorooctanoic acid	PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of GSTP1 mRNA]	18467677
D026023	Permethrin	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GSTP1 mRNA	28659758
D010575	Pesticides	GSTP1 gene polymorphism affects the susceptibility to Pesticides	16614106; 18603015; 23857610;
D010575	Pesticides	GSTP1 protein polymorphism affects the susceptibility to Pesticides	18215156; 28622826; 9802272;
D010578	Petroleum	Petroleum results in increased expression of GSTP1 mRNA	20821661
C058305	phenethyl isothiocyanate	GSTP1 protein affects the metabolism of phenethyl isothiocyanate	7826396
D010634	Phenobarbital	Phenobarbital results in decreased expression of GSTP1 protein	28541575
D010634	Phenobarbital	[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein	20935162
D010634	Phenobarbital	Phenobarbital results in increased expression of GSTP1 mRNA	23273579; 2563599;
D020113	Phenolphthalein	Phenolphthalein inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D010643	Phenoxybenzamine	Phenoxybenzamine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D010653	Phenylbutazone	Phenylbutazone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D010662	Phenylmercuric Acetate	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA	27188386
D010662	Phenylmercuric Acetate	Phenylmercuric Acetate results in increased expression of GSTP1 mRNA	26272509
D010695	Phlorhizin	Phlorhizin results in increased expression of GSTP1 mRNA	22538082
C030090	phosphoramide mustard	phosphoramide mustard results in increased expression of GSTP1 mRNA	25070981; 27888070;
C030090	phosphoramide mustard	phosphoramide mustard results in increased expression of GSTP1 protein	25070981
D010795	Phthalic Acids	Phthalic Acids results in increased expression of GSTP1 mRNA	21061450
D000077205	Pioglitazone	Pioglitazone inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	15526359
D010882	Piperonyl Butoxide	[Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of GSTP1 protein	18648771
C006253	pirinixic acid	pirinixic acid results in decreased expression of GSTP1 mRNA	12727805; 15375163; 18467677; 20813756; 20936131;
C006253	pirinixic acid	pirinixic acid results in decreased expression of GSTP1 protein	12727805; 15226431;
C006253	pirinixic acid	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GSTP1 mRNA]	18467677
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of GSTP1 mRNA]	24001438
D010936	Plant Extracts	Plant Extracts results in decreased expression of GSTP1 mRNA	15465739
D010936	Plant Extracts	[Resveratrol co-treated with Plant Extracts] results in increased expression of GSTP1 mRNA	21289251
D010936	Plant Extracts	Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 mRNA]	12497209
D010936	Plant Extracts	Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GSTP1 protein]	12497209
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	28804948
D010936	Plant Extracts	Plant Extracts results in decreased expression of GSTP1 mRNA	19650632
D010984	Platinum	[Acridine Orange binds to Platinum] which results in increased expression of GSTP1 mRNA	16814760
D010984	Platinum	GSTP1 protein affects the susceptibility to Platinum	15788669
D017671	Platinum Compounds	[Acridine Orange binds to Platinum Compounds] which results in increased expression of GSTP1 mRNA	16814760
C014758	plumbagin	plumbagin results in increased expression of GSTP1 mRNA	20028456
D011078	Polychlorinated Biphenyls	Polychlorinated Biphenyls results in increased expression of GSTP1 mRNA	31026535
D011084	Polycyclic Aromatic Hydrocarbons	GSTP1 gene affects the susceptibility to Polycyclic Aromatic Hydrocarbons	15938845
D011084	Polycyclic Aromatic Hydrocarbons	GSTP1 gene polymorphism affects the susceptibility to Polycyclic Aromatic Hydrocarbons	15466980
D011084	Polycyclic Aromatic Hydrocarbons	GSTP1 protein affects the metabolism of and results in decreased activity of Polycyclic Aromatic Hydrocarbons	15122594
D011084	Polycyclic Aromatic Hydrocarbons	GSTP1 protein polymorphism results in increased metabolism of Polycyclic Aromatic Hydrocarbons	15917149
D011084	Polycyclic Aromatic Hydrocarbons	GSTP1 protein polymorphism results in increased susceptibility to Polycyclic Aromatic Hydrocarbons	11740339
D011084	Polycyclic Aromatic Hydrocarbons	GSTP1 protein results in decreased activity of Polycyclic Aromatic Hydrocarbons	15122594
C095911	polycyclic aromatic hydrocarbons-DNA adduct	GSTP1 protein polymorphism results in increased abundance of polycyclic aromatic hydrocarbons-DNA adduct	11967624
D059808	Polyphenols	Polyphenols results in decreased expression of GSTP1 mRNA	15465739
D059808	Polyphenols	[Resveratrol co-treated with Polyphenols] results in increased expression of GSTP1 mRNA	21289251
C027373	potassium chromate(VI)	[Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of GSTP1 mRNA]	14625279
D011192	Potassium Dichromate	[Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of GSTP1 mRNA]	14625279
D011374	Progesterone	Progesterone results in decreased expression of GSTP1 mRNA	23018184
C015586	propiverine	propiverine binds to GSTP1 protein	29273565
D011692	Puromycin Aminonucleoside	Puromycin Aminonucleoside results in decreased expression of GSTP1 protein	19264907
D011716	Pyrantel Pamoate	Pyrantel Pamoate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D011718	Pyrazinamide	Pyrazinamide results in increased expression of GSTP1 mRNA	22431067
C030984	pyrene	pyrene results in increased expression of GSTP1 mRNA	15963578
D011729	Pyridostigmine Bromide	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GSTP1 mRNA	28659758
D011739	Pyrimethamine	Pyrimethamine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]	11807801
D011739	Pyrimethamine	Pyrimethamine results in decreased activity of GSTP1 protein	11807801
D011794	Quercetin	Quercetin inhibits the reaction [Quercetin results in increased expression of GSTP1 mRNA]	21256954
D011794	Quercetin	Quercetin results in decreased activity of GSTP1 protein	15041478
D011794	Quercetin	Quercetin results in increased expression of GSTP1 mRNA	21256954; 22197970;
D011794	Quercetin	SB 203580 inhibits the reaction [Quercetin results in increased expression of GSTP1 mRNA]	22197970
D011794	Quercetin	Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GSTP1 mRNA]	21294050
D011794	Quercetin	Quercetin results in increased expression of GSTP1 mRNA	22334599
D011794	Quercetin	Quercetin affects the expression of GSTP1 mRNA	18178720
D011794	Quercetin	Quercetin inhibits the reaction [Atrazine results in increased expression of GSTP1 mRNA]	23070809
D011794	Quercetin	Quercetin results in increased expression of GSTP1 mRNA	19191009
C012526	quercitrin	quercitrin results in decreased expression of GSTP1 mRNA	25193878
D011802	Quinidine	Quinidine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]	11807801
D011802	Quinidine	Quinidine results in decreased activity of GSTP1 protein	11807801
D011803	Quinine	Quinine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]	11807801
D011803	Quinine	Quinine results in decreased activity of GSTP1 protein	11807801
D000077185	Resveratrol	[Resveratrol co-treated with Plant Extracts] results in increased expression of GSTP1 mRNA	21289251
D000077185	Resveratrol	[Resveratrol co-treated with Polyphenols] results in increased expression of GSTP1 mRNA	21289251
D000077185	Resveratrol	Resveratrol results in increased expression of GSTP1 mRNA	12002526; 23750556;
D000077185	Resveratrol	Resveratrol results in increased expression of GSTP1 protein	25505154
C447880	retene	[Benzophenanthridines analog co-treated with benzo(b)fluorene co-treated with retene] results in increased expression of GSTP1 mRNA	22120849
D012176	Retinoids	Retinoids results in increased expression of GSTP1 protein	28886987
D012293	Rifampin	Rifampin results in increased expression of GSTP1 mRNA	22559005
D012293	Rifampin	[Rifampin co-treated with Monocrotophos] results in increased expression of GSTP1 mRNA	22733800
D012293	Rifampin	[Rifampin co-treated with Monocrotophos] results in increased expression of GSTP1 protein	22733800
D012293	Rifampin	Rifampin results in increased expression of GSTP1 mRNA	22733800
D012293	Rifampin	Rifampin results in increased expression of GSTP1 protein	22733800
D000077154	Rosiglitazone	Rosiglitazone inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	15526359
D000077154	Rosiglitazone	Rosiglitazone results in increased expression of GSTP1 mRNA	21515302
C018381	salvin	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of GSTP1 protein]]	25271104
C018381	salvin	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased expression of GSTP1 protein]	25271104; 26577515;
C018381	salvin	GSTP1 mutant form inhibits the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of GSTP1 protein]]	25271104; 25271104;
C018381	salvin	GSTP1 mutant form inhibits the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of CASP3 protein]]	25271104
C018381	salvin	NFE2L2 mutant form inhibits the reaction [salvin results in increased expression of GSTP1 protein]	26577515
C018381	salvin	salvin inhibits the reaction [Oxidopamine results in decreased expression of GSTP1 protein]	25271104
C018381	salvin	salvin results in increased expression of and results in increased activity of GSTP1 protein	25271104
C018381	salvin	salvin results in increased expression of GSTP1 protein	26577515
C005705	sanguinarine	sanguinarine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C005705	sanguinarine	sanguinarine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA]	15313406
C005705	sanguinarine	sanguinarine inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA]	15313406
C005705	sanguinarine	sanguinarine results in increased expression of GSTP1 protein	15981203
C093642	SB 203580	SB 203580 inhibits the reaction [Quercetin results in increased expression of GSTP1 mRNA]	22197970
C465222	S-decylglutathione	S-decylglutathione inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin]	9806904
D012643	Selenium	[Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA	19244175
D012643	Selenium	Selenium results in increased expression of GSTP1 mRNA	19244175
D012643	Selenium	Selenium affects the expression of GSTP1 protein	7532609
D018036	Selenium Compounds	Selenium Compounds results in increased expression of GSTP1 mRNA	12034368
D017279	Selenocysteine	Selenocysteine results in increased expression of GSTP1 mRNA	12034368
D012645	Selenomethionine	Selenomethionine results in decreased expression of GSTP1 mRNA	28962524
D012645	Selenomethionine	Selenomethionine results in decreased methylation of GSTP1 promoter	18676679
D012645	Selenomethionine	Selenomethionine results in increased expression of GSTP1 mRNA	18676679
D012645	Selenomethionine	Selenomethionine results in increased expression of GSTP1 protein	18676679
D012822	Silicon Dioxide	Silicon Dioxide analog results in increased expression of GSTP1 mRNA	22627296
D012822	Silicon Dioxide	Silicon Dioxide analog results in increased secretion of GSTP1 protein	25895662
D012834	Silver	Silver results in decreased expression of GSTP1 mRNA	24395442
D012834	Silver	Silver results in increased expression of GSTP1 mRNA	27131904
D012838	Silymarin	Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of GSTP1 mRNA]	23963992
D019821	Simvastatin	Simvastatin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C009277	sodium arsenate	sodium arsenate results in increased expression of GSTP1 mRNA	16882884
C017947	sodium arsenite	GSTP1 protein results in increased transport of sodium arsenite	12519079
C017947	sodium arsenite	NFE2L2A protein affects the reaction [sodium arsenite results in increased expression of GSTP1 mRNA]	27306194
C017947	sodium arsenite	sodium arsenite results in increased expression of GSTP1 mRNA	27306194; 29361514;
C017947	sodium arsenite	GSTP1 protein results in decreased susceptibility to sodium arsenite	18328521
C017947	sodium arsenite	sodium arsenite results in increased expression of GSTP1 mRNA	20339138
C017947	sodium arsenite	sodium arsenite affects the expression of GSTP1 mRNA	16507464
C017947	sodium arsenite	sodium arsenite results in increased expression of GSTP1 mRNA	14971641; 17451858;
C017947	sodium arsenite	sodium arsenite results in increased expression of GSTP1 protein	29044176
C017947	sodium arsenite	GSTP1 protein results in decreased susceptibility to sodium arsenite	11455017
C017947	sodium arsenite	sodium arsenite results in increased expression of GSTP1 mRNA	11241755; 11455017; 12799770; 16876216; 19933942; 21621526;
C017947	sodium arsenite	sodium arsenite results in increased expression of GSTP1 protein	11455017; 23137061; 29459688;
C017947	sodium arsenite	Vinyl Compounds analog promotes the reaction [sodium arsenite results in increased expression of GSTP1 mRNA]	21621526
C017947	sodium arsenite	sodium arsenite results in increased expression of GSTP1 protein	28249226
C016104	sodium bichromate	sodium bichromate results in increased expression of GSTP1 mRNA	22155349
D018038	Sodium Selenite	Sodium Selenite affects the reaction [H3-4 protein modified form binds to GSTP1 promoter]	18676679
D018038	Sodium Selenite	Sodium Selenite inhibits the reaction [GSTP1 protein SNP binds to and results in increased glutathionylation of Dinitrochlorobenzene]	22401947
D018038	Sodium Selenite	Sodium Selenite results in decreased methylation of GSTP1 promoter	18676679
D018038	Sodium Selenite	Sodium Selenite results in increased expression of GSTP1 mRNA	18676679
D018038	Sodium Selenite	Sodium Selenite results in increased expression of GSTP1 protein	18676679
D053260	Soot	GSTP1 gene polymorphism affects the susceptibility to Soot	20194081
D053260	Soot	Soot results in decreased expression of GSTP1 protein modified form	24464499
D053260	Soot	Soot results in increased expression of GSTP1 protein modified form	24464499
D053260	Soot	Soot affects the expression of GSTP1 mRNA	23065132
D013024	Soybean Oil	Soybean Oil promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 mRNA]	11600134
D013024	Soybean Oil	Soybean Oil promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GSTP1 protein]	11600134
D018119	Stavudine	Stavudine results in increased expression of GSTP1 mRNA	18299183
C025906	stilbene oxide	stilbene oxide results in increased expression of GSTP1 protein	9794803
D013311	Streptozocin	Streptozocin results in decreased expression of GSTP1 mRNA	25905778
C041711	St. Thomas' Hospital cardioplegic solution	St. Thomas' Hospital cardioplegic solution results in increased expression of GSTP1 mRNA	16214533
D020058	Styrene	GSTP1 exon polymorphism affects the susceptibility to Styrene	12604177
D020058	Styrene	GSTP1 gene polymorphism affects the susceptibility to Styrene	12397415
D020058	Styrene	GSTP1 gene polymorphism promotes the reaction [Styrene results in increased mutagenesis of HPRT1 gene]	12893075
D020058	Styrene	GSTP1 gene polymorphism results in increased susceptibility to Styrene	11535253
C013690	styrene oxide	GSTP1 exon polymorphism affects the susceptibility to styrene oxide	12694745
C033308	sulconazole	sulconazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D013420	Sulfamethoxazole	Sulfamethoxazole metabolite binds to and results in increased metabolism of GSTP1 protein	19358516
D013426	Sulfaphenazole	Sulfaphenazole inhibits the reaction [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac]	24246759
D012460	Sulfasalazine	Sulfasalazine results in decreased expression of GSTP1 mRNA	16141653
D013440	Sulfides	Sulfides inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased activity of GSTP1 protein]	15554553
C063871	sulfinosine	[sulfinosine co-treated with Curcumin] results in decreased expression of GSTP1 mRNA	18414057
D013442	Sulfinpyrazone	Sulfinpyrazone inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide]	15999103
D013448	Sulfobromophthalein	GSTP1 protein affects the metabolism of Sulfobromophthalein	3592675
C016766	sulforafan	sulforafan results in increased expression of GSTP1 mRNA	27306194
C016766	sulforafan	GSTP1 protein affects the metabolism of sulforafan	7826396
C016766	sulforafan	GSTP1 protein binds to sulforafan	21838287
C016766	sulforafan	sulforafan results in decreased activity of GSTP1 protein	17937621
C016766	sulforafan	NFE2L2 protein promotes the reaction [sulforafan results in increased expression of GSTP1 mRNA]	20932822
C016766	sulforafan	sulforafan results in increased expression of GSTP1 mRNA	19303893; 20932822;
C016766	sulforafan	sulforafan results in increased expression of GSTP1 protein	19303893
C016766	sulforafan	N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [sulforafan results in increased expression of GSTP1 mRNA]	21871945
C016766	sulforafan	sulforafan inhibits the reaction [N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GSTP1 mRNA]	21871945
C016766	sulforafan	sulforafan promotes the reaction [JUN protein binds to GSTP1 enhancer]	20237067
C016766	sulforafan	[sulforafan promotes the reaction [JUN protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA	20237067; 20237067;
C016766	sulforafan	sulforafan promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]	20237067
C016766	sulforafan	[sulforafan promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA	20237067; 20237067;
C016766	sulforafan	sulforafan results in increased expression of and results in increased activity of GSTP1 protein	20237067
C016766	sulforafan	sulforafan results in increased expression of GSTP1 mRNA	20237067; 21871945;
C009359	sulfotepp	sulfotepp results in decreased activity of GSTP1 protein	18409811
C025462	sulindac sulfide	sulindac sulfide binds to and results in decreased activity of GSTP1 protein	15300575
C025463	sulindac sulfone	sulindac sulfone binds to and results in decreased activity of GSTP1 protein	15300575
D013605	T-2 Toxin	T-2 Toxin affects the expression of GSTP1 protein	26141394
D013629	Tamoxifen	Tamoxifen results in increased expression of GSTP1	26584595
D013629	Tamoxifen	GSTP1 protein polymorphism affects the susceptibility to Tamoxifen	15565566
D013629	Tamoxifen	Tamoxifen results in increased expression of GSTP1 mRNA	25123088
C021751	tanshinone	tanshinone results in decreased expression of GSTP1 mRNA	21165580
C031655	tauroursodeoxycholic acid	tauroursodeoxycholic acid results in increased expression of GSTP1 mRNA	15885361
D013662	Tea	Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTP1 protein]	12725062
D013662	Tea	Tea inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of GSTP1 protein]	12725062
D000002	Temefos	Temefos inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D013713	Teniposide	Teniposide inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D000077291	Terbinafine	Terbinafine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D020122	tert-Butylhydroperoxide	NFE2L2 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA]	19233942
D020122	tert-Butylhydroperoxide	tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA	19233942; 27750016; 28212397;
D020122	tert-Butylhydroperoxide	tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA	15336504
C501413	tesaglitazar	tesaglitazar results in decreased expression of GSTP1 mRNA	21515302
D043343	Testosterone Propionate	Testosterone Propionate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
C020806	tetrabromobisphenol A	tetrabromobisphenol A affects the expression of GSTP1 mRNA	18976794
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of GSTP1 mRNA	15716485
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of GSTP1 mRNA	15056799; 19542225; 23669205;
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of GSTP1 mRNA	18343893; 20702594; 21570461; 26377647; 28922406;
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of GSTP1 protein	28922406
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GSTP1 gene]	28213091
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of GSTP1 mRNA	19465110; 28213091;
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of GSTP1 mRNA	15034205; 26290441;
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of GSTP1 mRNA	22298810
D013752	Tetracycline	Tetracycline affects the expression of GSTP1 mRNA	25064622
D013752	Tetracycline	Tetracycline inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]	11807801
D013752	Tetracycline	Tetracycline results in decreased activity of GSTP1 protein	11807801
D013755	Tetradecanoylphorbol Acetate	beta-lapachone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA]	15313406
D013755	Tetradecanoylphorbol Acetate	Capsaicin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA]	15313406
D013755	Tetradecanoylphorbol Acetate	Emodin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA]	15313406
D013755	Tetradecanoylphorbol Acetate	sanguinarine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA]	15313406
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate promotes the reaction [GATA1 protein binds to GSTP1 promoter]	14623254
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in decreased expression of GSTP1 mRNA	14623254
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in decreased expression of GSTP1 protein	14623254
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA	15313406; 15533597;
D013755	Tetradecanoylphorbol Acetate	[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GSTP1 mRNA	19840844
D013755	Tetradecanoylphorbol Acetate	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GSTP1 mRNA	25613284
D013806	Theophylline	Theophylline results in decreased expression of GSTP1 mRNA	22982570
D013827	Thiabendazole	Thiabendazole results in increased expression of GSTP1 mRNA	15110098
D013853	Thioacetamide	Thioacetamide affects the expression of GSTP1 mRNA	25064622
D013853	Thioacetamide	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of GSTP1 mRNA	28943392
D013853	Thioacetamide	Thioacetamide results in increased expression of GSTP1 mRNA	10634158; 23411599;
D013853	Thioacetamide	Thioacetamide results in increased expression of GSTP1 protein	10634158
D008063	Thioctic Acid	Thioctic Acid promotes the reaction [JUN protein binds to GSTP1 enhancer]	20237067
D008063	Thioctic Acid	[Thioctic Acid promotes the reaction [JUN protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA	20237067; 20237067;
D008063	Thioctic Acid	Thioctic Acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]	20237067
D008063	Thioctic Acid	[Thioctic Acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA	20237067; 20237067;
D008063	Thioctic Acid	Thioctic Acid results in increased expression of and results in increased activity of GSTP1 protein	20237067
D008063	Thioctic Acid	Thioctic Acid results in increased expression of GSTP1 mRNA	20237067
D013876	Thiophenes	Thiophenes analog promotes the reaction [Tretinoin results in increased expression of GSTP1 mRNA]	16140955
D013883	Thiostrepton	Thiostrepton inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D013852	Thiotepa	GSTP1 gene affects the reaction [Glutathione affects the metabolism of Thiotepa]	10334868
D013852	Thiotepa	GSTP1 gene affects the susceptibility to Thiotepa	10334868; 12360105;
D013852	Thiotepa	GSTP1 gene polymorphism affects the metabolism of Thiotepa	10334868
D013852	Thiotepa	GSTP1 gene polymorphism results in decreased susceptibility to Thiotepa	10334868
D013852	Thiotepa	GSTP1 gene SNP affects the export of Thiotepa	19076156
D013852	Thiotepa	GSTP1 protein affects the metabolism of [Thiotepa co-treated with Glutathione]	7712478
D013852	Thiotepa	GSTP1 protein affects the susceptibility to Thiotepa	10334868; 19076156;
D013852	Thiotepa	GSTP1 protein results in increased metabolism of Thiotepa	10334868
C411320	thonningianin A	thonningianin A results in decreased activity of GSTP1 protein	15234070
D008625	Tiopronin	Tiopronin inhibits the reaction [chlorobenzene results in increased expression of GSTP1 protein]	19800902
C009495	titanium dioxide	titanium dioxide results in decreased phosphorylation of GSTP1 protein	21439344
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased expression of GSTP1 mRNA	27576004
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution affects the expression of GSTP1 mRNA	29505817
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution affects the expression of GSTP1 protein	30291989
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in decreased expression of GSTP1 mRNA	30610935
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased metabolism of GSTP1 protein	23396223
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased susceptibility to GSTP1 protein polymorphism	23643483
D014028	Tobacco Smoke Pollution	[APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of GSTP1 mRNA	24096154
D014028	Tobacco Smoke Pollution	[Vehicle Emissions analog co-treated with Coal Tar analog co-treated with Tobacco Smoke Pollution analog] results in increased expression of GSTP1 mRNA	22935520
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased expression of GSTP1 protein	29545142
D014047	Tolnaftate	Tolnaftate inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D014050	Toluene	GSTP1 gene polymorphism affects the susceptibility to Toluene	17292523
D014050	Toluene	Toluene affects the expression of GSTP1 mRNA	18653662
D014051	Toluene 2,4-Diisocyanate	GSTP1 gene polymorphism affects the metabolism of Toluene 2,4-Diisocyanate	20032816
D014051	Toluene 2,4-Diisocyanate	GSTP1 gene polymorphism affects the susceptibility to Toluene 2,4-Diisocyanate	20032816
C012293	tranilast	tranilast inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D014212	Tretinoin	Tretinoin results in decreased expression of GSTP1 mRNA	20530235; 30248606;
D014212	Tretinoin	Thiophenes analog promotes the reaction [Tretinoin results in increased expression of GSTP1 mRNA]	16140955
D014212	Tretinoin	Tretinoin results in increased expression of GSTP1 mRNA	16140955; 16882163;
D014212	Tretinoin	Tretinoin results in decreased expression of GSTP1 protein	1917145
C012589	trichostatin A	trichostatin A results in increased expression of GSTP1 mRNA	15901671
C012589	trichostatin A	[Decitabine co-treated with trichostatin A] results in increased expression of GSTP1 mRNA	17891453
C012589	trichostatin A	trichostatin A affects the expression of GSTP1 protein	19294695
C012589	trichostatin A	[Decitabine co-treated with trichostatin A] results in increased expression of GSTP1 mRNA	19444856
D014266	Trientine	Trientine results in decreased expression of GSTP1 protein	12883709
C020946	triethylene glycol dimethacrylate	GSTP1 gene polymorphism results in increased susceptibility to triethylene glycol dimethacrylate	15557397
C020946	triethylene glycol dimethacrylate	triethylene glycol dimethacrylate binds to and results in decreased activity of GSTP1 protein	15557397
C020946	triethylene glycol dimethacrylate	triethylene glycol dimethacrylate results in increased activity of GSTP1 protein	15557397
D013721	Triethylenephosphoramide	GSTP1 gene SNP affects the export of Triethylenephosphoramide	19076156
D013721	Triethylenephosphoramide	GSTP1 protein affects the susceptibility to Triethylenephosphoramide	19076156
C010360	triethyllead	triethyllead results in increased expression of GSTP1 mRNA	9020200
D014284	Triiodothyronine	Triiodothyronine inhibits the reaction [goitrin results in increased expression of GSTP1 protein]	7532609
C052920	trimethylarsine oxide	trimethylarsine oxide results in increased expression of GSTP1 mRNA	17481689
D014303	Trinitrotoluene	Trinitrotoluene affects the expression of GSTP1 mRNA	21346803
C012085	tris(2,3-dibromopropyl)phosphate	GSTP1 protein affects the metabolism of tris(2,3-dibromopropyl)phosphate	8242859
C012085	tris(2,3-dibromopropyl)phosphate	GSTP1 protein results in increased susceptibility to tris(2,3-dibromopropyl)phosphate	8242859
D014315	Triterpenes	Triterpenes results in increased expression of GSTP1 mRNA	18544911
D000077288	Troglitazone	Troglitazone metabolite binds to GSTP1 protein	21639118
D000077288	Troglitazone	Troglitazone metabolite results in decreased activity of GSTP1 protein	21639118
D000077288	Troglitazone	Troglitazone inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]	15526359
D000077288	Troglitazone	Troglitazone results in increased expression of GSTP1 mRNA	21515302
C113580	U 0126	U 0126 results in increased expression of GSTP1 mRNA	26494252
C112106	UAB 30	UAB 30 analog results in increased expression of GSTP1 mRNA	23292798
C112106	UAB 30	UAB 30 results in increased expression of GSTP1 mRNA	23292798
D014501	Uranium	Uranium analog results in decreased expression of GSTP1 mRNA	27544493
D014635	Valproic Acid	Valproic Acid affects the expression of GSTP1 mRNA	25064622
D014635	Valproic Acid	Valproic Acid results in increased expression of GSTP1 mRNA	15901671
D014635	Valproic Acid	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA	27188386
D014635	Valproic Acid	Valproic Acid results in increased expression of GSTP1 mRNA	23179753; 24383497; 24935251; 26272509; 29154799;
D014635	Valproic Acid	Valproic Acid affects the expression of GSTP1 mRNA	17292431
D001335	Vehicle Emissions	GSTP1 gene polymorphism affects the susceptibility to Vehicle Emissions	20194081
D001335	Vehicle Emissions	GSTP1 gene SNP results in increased susceptibility to Vehicle Emissions	18950799
D001335	Vehicle Emissions	Vehicle Emissions affects the methylation of GSTP1 gene	25487561
D001335	Vehicle Emissions	[Vehicle Emissions analog co-treated with Coal Tar analog co-treated with Tobacco Smoke Pollution analog] results in increased expression of GSTP1 mRNA	22935520
D001335	Vehicle Emissions	[Vehicle Emissions analog co-treated with Coal Tar analog] results in increased expression of GSTP1 mRNA	22935520
D001335	Vehicle Emissions	Vehicle Emissions analog results in increased expression of GSTP1 mRNA	12011483
D001335	Vehicle Emissions	Vehicle Emissions results in decreased expression of GSTP1 mRNA	23905969
D001335	Vehicle Emissions	Vehicle Emissions results in increased expression of GSTP1 mRNA	22352393
D001335	Vehicle Emissions	Vehicle Emissions results in increased expression of GSTP1 protein	18474546
C059141	verlukast	verlukast inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide]	15999103
D014747	Vinblastine	GSTP1 protein results in decreased susceptibility to Vinblastine	11455017
C025643	vinclozolin	vinclozolin results in increased expression of GSTP1 mRNA	18220299
D014750	Vincristine	GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]	10900222
D014750	Vincristine	GSTP1 protein results in decreased susceptibility to Vincristine	10900222
D014752	Vinyl Chloride	GSTP1 gene polymorphism affects the susceptibility to Vinyl Chloride	20134343
D014752	Vinyl Chloride	GSTP1 gene SNP results in increased susceptibility to Vinyl Chloride	20100738
D014753	Vinyl Compounds	Vinyl Compounds analog promotes the reaction [sodium arsenite results in increased expression of GSTP1 mRNA]	21621526
D014801	Vitamin A	Vitamin A inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D014810	Vitamin E	[Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA	19244175
D014810	Vitamin E	Vitamin E results in increased expression of GSTP1 mRNA	19244175
D010837	Vitamin K 1	Vitamin K 1 inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]	23769903
D000077337	Vorinostat	Vorinostat results in decreased expression of GSTP1 protein	17593366
D000077191	Wortmannin	Wortmannin inhibits the reaction [Cadmium Chloride results in increased expression of GSTP1 mRNA]	24316436
C020174	WR 1065	WR 1065 results in decreased expression of GSTP1 mRNA	12007958
C104536	xanthohumol	xanthohumol results in increased expression of GSTP1 mRNA	23085367
C104536	xanthohumol	xanthohumol results in increased expression of GSTP1 protein	23085367
D065146	Zeaxanthins	Zeaxanthins binds to GSTP1 protein	15355982; 15949677;
C403304	zerumbone	zerumbone results in increased expression of GSTP1 mRNA	15122579
C016837	zinc chloride	[Cadmium Chloride co-treated with zinc chloride] results in increased expression of GSTP1 protein	15602745

Functional annotations

Keywords

Keyword ID	Keyword Term
KW-0002	3D-structure
KW-0007	Acetylation
KW-0963	Cytoplasm
KW-0903	Direct protein sequencing
KW-0496	Mitochondrion
KW-0539	Nucleus
KW-0597	Phosphoprotein
KW-0621	Polymorphism
KW-1185	Reference proteome
KW-0808	Transferase

Interpro

InterPro ID	InterPro Term
IPR010987	Glutathione-S-Trfase_C-like
IPR036282	Glutathione-S-Trfase_C_sf
IPR040079	Glutathione_S-Trfase
IPR004045	Glutathione_S-Trfase_N
IPR004046	GST_C
IPR003082	GST_pi
IPR036249	Thioredoxin-like_sf

PROSITE

PROSITE ID	PROSITE Term
PS50405	GST_CTER
PS50404	GST_NTER

Pfam

Pfam ID	Pfam Term
PF14497	GST_C_3
PF02798	GST_N

Gene: GSTP1

Basic information

Gene expression information

Gene expression in different tissues (GTEx V7)

Gene expression in different tissues (ENCODE)

Protein structural annotations

3D structure in PDB database

Protein disorder information

Orthologous information

There is no orthologous record for this gene !

Identified variants/mutations related to cleft phenotype

Other genetic variants/mutations

Disease or phenotype associated information

Gene Ontology (GO)/biological pathways

GO:Molecular Function

GO:Biological Process

GO:Cellular Component

Reactome Pathway

Drugs and compounds information

Functional annotations

Keywords

Interpro

PROSITE

Pfam

Protein-protein interaction

Protein-miRNA interaction